---

Get the BackTable app
https://www.backtable.com/app

---

Timestamps

00:00 - Introduction
05:04 - Case: Male Urinary Retention
12:38 - Case: Failed Sling
18:44 - Case: Parkinson’s OAB
21:50 - Case: Post-Prostatectomy
26:48 - Prolapse Without Urodynamics
32:29 - Obstruction Workup
36:16 - Refractory OAB
42:49 - Interstitial Cystitis
45:18 - Recurrent UTI Evaluation
50:16 - Conclusions

---

More about this episode

They review guideline-driven indications and limitations of urodynamic testing, emphasizing that many common conditions do not routinely require testing. Through case-based discussion, they highlight situations where urodynamics can meaningfully inform care, such as complex neurogenic patients and cases requiring differentiation between obstruction and detrusor underactivity. The conversation highlights the importance of clinical judgment, targeted use of adjuncts such as uroflow, and aligning testing with decision-making to optimize patient outcomes.
This podcast is supported by the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU).

---

Resources

Female Urgency, Trial of Urodynamics as Routine Evaluation (FUTURE study)
https://pubmed.ncbi.nlm.nih.gov/34702331/

---

BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists.

Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.

► https://www.backtable.com/app

---

Get the BackTable app
https://www.backtable.com/app

---

Timestamps

00:00 - Introduction
02:43 - How Yes Changes Over Time
11:34 - Power Dynamics For Trainees
16:11 - Housekeeping Work
18:46 - Kind Versus Nice
22:52 - Delegating And Mentoring
28:07 - Decision-Making Framework
36:21 - FOMO Versus Opportunity
40:30 - Mentorship
45:02 - Final Takeaways

---

More about this episode

Early in training, saying yes is often driven by power dynamics, while later in a career, it’s competing priorities that make those decisions harder. According to Dr. Cameron, a clear, timely “no” is not only acceptable but often more professional than a delayed response, and leaders play a key role in reinforcing this by giving trainees the space to decline opportunities. This episode also highlights the disproportionate share of “housekeeping” work taken on by women and junior faculty, adding another layer to these decisions. To navigate these challenges, Dr. Cameron offers a practical framework that considers time, role expectations, energy, personal fulfillment, CV value, and long-term goals, while emphasizing the role of mentors and trusted colleagues in providing perspective.

---

Resources

Society of Women in Urology (SWIU)
https://swiu.org/home.aspx

---

BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists.

Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.

► https://www.backtable.com/app

---

Get the BackTable app

https://www.backtable.com/app

---

Timestamps

00:00 - Introduction
01:44 - Why Use PAE in Cancer
04:08 - Neoadjuvant and Salvage Use
07:26 - Radiation Planning Benefits
12:51 - PAE vs. Surgery
18:36 - SBRT Access
20:48 - Current Evidence and Trials
25:29 - Patient Selection
32:18 - PAE After Radiation
36:56 - When to Avoid PAE
40:29 - Long-Term Implications
44:28 - Conclusions

---

More about this episode

They review how PAE can improve lower urinary tract symptoms and reduce prostate volume, potentially optimizing patients for radiation therapy, including stereotactic body radiotherapy (SBRT) and brachytherapy. The discussion highlights early clinical data and patient selection considerations such as gland size and symptom burden. Finally, they examine post-radiation applications, technical challenges, and current limitations, emphasizing the need for larger, multicenter trials to better define PAE’s role in prostate cancer treatment pathways.

---

Resources

Prostate Artery Embolization in the Setting of Prostate Cancer: Review and Opinion
https://pmc.ncbi.nlm.nih.gov/articles/PMC11775958/

---

Get the BackTable app
https://www.backtable.com/app

---

Timestamps

00:00 - Introduction
03:06 - 2024 AUA/SUFU Idiopathic OAB Guideline
07:32 - Patient Experience with OAB
11:59 - Beta-3 Agonists vs Anticholinergics
15:15 - Botox Counseling and Dosing
18:11 - Tibial Nerve Stimulation
25:47 - Sacral Neuromodulation
32:09 - Cost Burden of OAB
39:38 - Evolution of OAB Care
41:39 - Future Research Directions

---

More about this episode

The conversation positions OAB as a clinical diagnosis, supported by focused initial evaluation and selective use of advanced testing, with attention to the emerging role of ambulatory urodynamics. Dr. Kim and Dr. Kapur review management across the care continuum, including behavioral strategies, pelvic floor physical therapy, and pharmacologic options, with consideration of beta-3 agonists in older patients. The discussion also focuses on earlier use of minimally invasive therapies such as intradetrusor Botox and neuromodulation, and how introducing these options sooner may improve follow-up, reduce delays, and help patients achieve symptom control more efficiently.

---

Resources

The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder (2024)
https://www.auanet.org/guidelines-and-quality/guidelines/idiopathic-overactive-bladder

Anticholinergic Drug Exposure and the Risk of Dementia
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2736353

Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial

https://pubmed.ncbi.nlm.nih.gov/20171677/

Trends in Utilization of Sacral Neuromodulation for Overactive Bladder: Insight From the AUA AQUA Registry
https://www.auajournals.org/doi/10.1097/UPJ.0000000000000916

A retrospective longitudinal evaluation of new overactive bladder patients in an FPMRS urologist practice: Are patients following up and utilizing third-line therapies?
https://pubmed.ncbi.nlm.nih.gov/33197059/

---

Get the BackTable app

https://www.backtable.com/app

---

Timestamps

00:00 - Introduction
05:09 - Who Manages GU Trauma?
13:53 - Purpose of ACS Guidelines
16:13 - Development of ACS Guidelines
20:01 - Foley Catheter Debate
23:26 - Renal Trauma
26:40 - Imaging Protocols and Delays
29:30 - Bladder Trauma and Special Populations
33:15 - Urethral Injuries
38:02 - Genital Wounds and Antibiotics
39:42 - Transfer Criteria and Resources
41:26 - Conclusions

---

More about this episode

Dr. Johnson and Dr. Koch review the rationale for developing multidisciplinary guidelines and the variability in genitourinary trauma care across institutions. The discussion highlights key management principles, including non-operative strategies for renal trauma, decision-making in bladder and urethral injuries, and how urinary diversion impacts orthopedic and trauma surgical planning. The episode also addresses considerations for special populations, long-term functional outcomes, and practical implementation tools, such as the ACS gap analysis checklist, designed to improve coordination and quality of care across trauma systems.

---

Resources

ACS Best Practices Guidelines: Management of Genitourinary Injuries (August 2025)
https://www.facs.org/media/ya5hcu0s/genitourinary_guidelines.pdf

---

SYNPOSIS

Dr. Mehta and Dr. Nam review the key changes in vasectomy guidelines. They address common misconceptions about sexual function and long-term health risks, as well as the role of telemedicine consultation and day-of-procedure examination. Their discussion also covers recommended surgical techniques and updated guidance on post-vasectomy semen analysis, including mail-in testing options. Finally, Dr. Mehta outlines fertility considerations after vasectomy, including cryopreservation, reversal, and sperm retrieval with IVF, and how clinicians can counsel patients about expectations and referral pathways.

---

TIMESTAMPS
00:00 - Introduction
02:07 - Why Update the Guidelines
05:38 - Key Guideline Changes
11:02 - Sexual Function Concerns
17:19 - Health Risks Debunked
21:28 - Periprocedural Best Practices
28:25 - Semen Analysis Follow Up
37:12 - Future of Male Contraception
39:11 - Conclusions

---

RESOURCES

Vasectomy: AUA Guideline (2026)
https://www.auanet.org/guidelines-and-quality/guidelines/vasectomy-guideline

---

This podcast was developed in collaboration with:

Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
https://sufuorg.com/home.aspx

---

SYNPOSIS

Through a case-based approach, they review initial evaluation strategies including symptom history, validated questionnaires, uroflowmetry, post-void residual measurement, and when tools like voiding diaries can help clarify the diagnosis. The conversation then moves to management, outlining a stepwise approach from behavioral interventions and medications to surgical options when symptoms persist. The doctors discuss how prostate anatomy, side effect profiles, and patient priorities guide treatment selection, when urodynamics may add diagnostic clarity, and why addressing outlet obstruction early may help prevent more difficult-to-treat bladder dysfunction over time.

---

TIMESTAMPS

00:00 - Introduction
06:31 - Workup for Frequency and Nocturia
11:41 - When to Use a Voiding Diary
19:18 - Behavioral Therapy
26:40 - Post-Finasteride Syndrome
30:03 - Surgical Options
44:41 - Nocturia Counseling
47:32 - Botox With Outlet Surgery
49:47 - When to Order Urodynamics
54:14 - Bladder or Prostate?

---

RESOURCES

Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
https://sufuorg.com/home

---

SYNPOSIS

The conversation also explores operative pearls, the role of technologies like the Optilume balloon, and why thoughtful short-term follow up is critical for both patient outcomes and clinician learning. Together, they emphasize a measured, conservative mindset whenever appropriate to minimize morbidity while delivering high-quality trauma care.

---

TIMESTAMPS

00:00 - Introduction
03:07 - Kidney and Ureteric Trauma
19:16 - Urethral Trauma
34:42 - MRI vs Ultrasound
47:56 - Collaboration in Reconstructive Urology
52:26 - Testicular Trauma
57:29 - Epididymal Injury
01:02:35 - Follow-Ups Matter
01:05:14 - Foreign Body Stories
01:06:52 - Career Advice

---

SYNPOSIS

They review a structured approach from initial evaluation and physical examination to pain management. The discussion outlines an evidence-informed, multimodal management framework incorporating medications, pelvic floor physical therapy, behavioral health interventions, neuromodulators, and selective procedural strategies, with an emphasis on realistic expectation setting in this complex patient population.

---

TIMESTAMPS

00:00 - Introduction
01:41 - Path to Chronic Pelvic Pain Work
08:19 - Getting Involved with the AUA
13:02 - Developing Guidelines
19:56 - Initial Patient Evaluation
27:11 - Setting Expectations
32:05 - Making the Diagnosis
35:17 - Success Rates and Counseling Patients
39:51 - Central Sensitization
44:31 - Physical Exam Recommendations
49:26 - Non-Pharmacologic Options
54:38 - Follow Up Cadence
01:02:24 - Chronic Scrotal Pain vs CPPS
01:08:26 - Conclusion

---

RESOURCES

Diagnosis and Management of Male Chronic Pelvic Pain (Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Chronic Scrotal Content Pain): AUA Guideline (2025)
https://www.auanet.org/guidelines-and-quality/guidelines/male-chronic-pelvic-pain

---

SYNPOSIS

The conversation reviews early outcomes showing high rates of pathologic downstaging and the possibility that many patients may avoid additional systemic therapy after surgery, while emphasizing this approach is not yet standard of care. Dr. Khanna highlights coordination with medical oncology, radiology, and pathology, postoperative considerations, and the potential future role of biomarkers such as ctDNA. Ultimately, the episode underscores the need for clinical trials and thoughtful patient selection as clinicians navigate integrating surgery into an evolving systemic therapy landscape.

---

TIMESTAMPS

00:00 - Introduction
02:19 - The Evolution of Urothelial Carcinoma Treatment
05:23 - Rationale for Consolidative Surgery
12:32 - Patient Selection Criteria
15:23 - Surgical Approach and Considerations
23:58 - Pathologic Findings
31:34 - The Role of Radiation
39:38 - Biomarkers
44:10 - Prospective Trials and Future Directions
53:06 - Guidance for Urologists

---

RESOURCES

Consolidative Surgery for Advanced Urothelial Carcinoma Following Induction Enfortumab Vedotin and/or Immune Checkpoint Inhibitor Therapy: A Multicenter Analysis
https://pubmed.ncbi.nlm.nih.gov/40425390/

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
https://www.nejm.org/doi/full/10.1056/NEJMoa2312117

Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer
https://www.nejm.org/doi/abs/10.1056/NEJMoa2401497

---

SYNPOSIS

Throughout the conversation, Dr. Breyer reflects on his path into the subspecialty and breaks down the evolution of reconstructive practice, particularly the shift from anastomotic urethroplasty to non-transecting techniques. Dr. Breyer and Dr. Koch also discuss managing complex urethral strictures, including cases involving prior radiation and inflammatory conditions, while emphasizing thoughtful patient selection and surgical planning. Finally, they explore the current training landscape, challenges in patient access to subspecialty reconstructive care, and why patient-reported outcomes will play a central role in shaping future innovation in urethral reconstruction.

---

TIMESTAMPS

00:00 - Introduction
05:40 - Evolution of Surgical Techniques
10:01 - Managing Complex Cases
14:19 - Education and Training in Reconstructive Urology
23:45 - The Future of Reconstructive Urology
28:45 - The Journey of a Reconstructive Urologist
30:45 - Challenges in Urology Training and Practice
35:35 - Addressing Urologist Shortages in Rural Areas
48:34 - Innovations and Research in Reconstructive Urology
57:25 - Final Thoughts

---

SYNPOSIS

The conversation explores emerging tools that can refine surveillance decisions, including PSA density, MRI findings, genomic classifiers, and the growing role of AI-assisted pathology. Dr. de la Calle emphasizes the importance of nuanced patient counseling, acknowledging anxiety and long-term risk while reinforcing that time on active surveillance can be a meaningful win when oncologic outcomes remain comparable to upfront treatment.

---

TIMESTAMPS

00:00 - Introduction
02:58 - Current Evidence
05:03 - Patient Selection Criteria
12:11 - Importance of PSA Density and Monitoring Protocols
18:12 - Pathology and Genomic Testing
32:18 - Future Directions and Research
36:33 - Key Takeaways

---

RESOURCES

ProtecT Trial: Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
https://www.nejm.org/doi/full/10.1056/NEJMoa2214122

Canary PASS Study
https://canarypass.org/

Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial
https://pubmed.ncbi.nlm.nih.gov/37137444

---

SYNPOSIS

The doctors examine the evolving management of muscle-invasive bladder cancer (MIBC), including the role of neoadjuvant and adjuvant therapies, the integration of immunotherapy, and the recent approval of enfortumab vedotin plus pembrolizumab. The discussion explores the rapidly changing perioperative landscape, the prognostic utility of ctDNA, and how biomarkers such as HER2 and FGFR are influencing treatment selection across disease states. They also address bladder preservation strategies, management of treatment-related toxicities, and the importance of multidisciplinary coordination. The episode concludes with a forward-looking discussion on emerging therapies and the potential to improve cure rates in bladder cancer.

---

TIMESTAMPS

00:00 - Introduction
01:44 - Overview of Bladder Cancer Treatment
04:54 - Patient Staging and Treatment Goals
10:12 - Bladder Preservation vs. Radical Cystectomy
16:39 - Emerging Trials and Future Directions
22:40 - ctDNA and Precision Medicine
33:50 - Metastatic Disease and Biomarker Strategies
42:16 - Managing Neuropathy in Metastatic Treatment
48:44 - HER2 and FGFR in Bladder Cancer
54:15 - Future Directions in Bladder Cancer Treatment

---

RESOURCES

EV-302/303 Trial
https://newsroom.astellas.com/2023-12-15-PADCEV-R-enfortumab-vedotin-ejfv-with-KEYTRUDA-R-pembrolizumab-Approved-by-FDA-as-the-First-and-Only-ADC-Plus-PD-1-to-Treat-Advanced-Bladder-Cancer

NIAGARA Regimen
https://www.nejm.org/doi/full/10.1056/NEJMoa2408154

KEYNOTE-905 Study
https://www.annalsofoncology.org/article/S0923-7534(25)04894-X/fulltext

---

SYNPOSIS

The discussion centers on real-world clinical challenges, particularly in high-risk populations such as patients with neurogenic bladder, chronic catheterization, or prior reconstruction - groups in whom antibiotics are frequently used prophylactically or indefinitely. Drs. Sterling and Koch explore how well-intentioned prescribing patterns can contribute to resistance, dysbiosis, and recurrent infection, while often failing to address the underlying drivers of disease.

Rather than framing infection control solely around eradication, the conversation considers a shift toward modulation of the urinary microbiome, drawing on lessons from gastroenterology, infectious disease, and transplant medicine. The episode concludes by outlining how a more nuanced, multidisciplinary approach may better serve reconstructive urology patients in the long term.

---

TIMESTAMPS

00:00 - Introduction
02:22 - Antibiotic Stewardship in Urology
06:34 - Current Landscape of Antibiotic Use
13:44 - Protocols and Practices in Reconstruction
18:24 - Antibiotic Overuse and Misuse
21:02 - Shifting the Microbiome
25:12 - Chlorhexidine Irrigations
32:38 - Future Directions
38:27 - Implementing Antibiotic Protocols
40:48 - Conclusions

---

RESOURCES

STOP-IT Trial
https://www.nejm.org/doi/full/10.1056/NEJMoa1411162

---

This podcast was developed in collaboration with:

Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)

https://sufuorg.com/home.aspx

---

SYNPOSIS

The discussion revolves around the broad definition of vaginal rejuvenation, distinguishing between medical and cosmetic interventions. They address common misconceptions, the roles of different health professionals, and emphasize the importance of pelvic floor physical therapy and the appropriate use of systemic and vaginal estrogen therapy. The conversation also highlights critical gaps in research surrounding laser and radiofrequency interventions, underscoring the need for stronger evidence, clearer patient education, and continued advocacy around menopause care and sexual function.

---

TIMESTAMPS

00:00 - Introduction
02:07 - Defining Vaginal Rejuvenation
04:31 - Common Procedures and Misconceptions
10:00 - Insurance and Coverage of Procedures
12:00 - Laser and Radiofrequency Therapies
18:06 - Vaginal Estrogen and Lift of Black Box Warning
19:55 - The Role of Systemic Hormone Therapy
26:52 - Vaginal Rejuvenation Misconceptions
32:17 - Pelvic Floor Physical Therapy and Timing of Procedures
34:20 - Regional Variations in Therapeutic Availability
38:36 - Gender Inequity in Healthcare
40:12 - Final Thoughts

---

RESOURCES

Joint Report on Terminology for Cosmetic Gynecology
https://journals.lww.com/fpmrs/abstract/2022/06000/joint_report_on_terminology_for_cosmetic.2.aspx

---

SYNPOSIS

The conversation explores fellowship models, academic versus private practice settings, and the role of multidisciplinary teams in supporting surgical programs. Practical considerations around patient screening, care coordination, and insurance are addressed, reframing gender affirming surgery as a core component of modern urologic care rather than a subspecialty outlier.

---

TIMESTAMPS

00:00 - Introduction
00:52 - Journey to Gender Affirming Surgery
03:29 - Specialized Training in Gender Surgery
09:34 - Building a Gender Surgery Program
27:54 - Providing Competent and Affirming Care
32:54 - Future of Gender Affirming Surgery in Urology
39:58 - Final Thoughts and Advice

---

RESOURCES

World Professional Association for Transgender Health (WPATH) Standards of Care:
https://wpath.org/publications/soc8/

---

SYNPOSIS

Together, the doctors explore the realities that new attendings face, from building efficient clinical systems to managing complications and building support networks. Drawing from personal experience, the guests offer practical guidance on mentorship, recognizing when a role or environment may no longer be the right fit, and building a sustainable, fulfilling professional life.

---

TIMESTAMPS

00:00 - Introduction
02:54 - Early Challenges
06:13 - Finding Support and Building Systems
11:49 - Balancing Work and Personal Life
15:52 - The Importance of Saying Yes Early On
18:16 - Mentorship and Finding Allies
22:29 - Decision Making and Cognitive Biases
24:36 - Managing Complications
27:31 - Prioritizing Clinical Goals
38:45 - Knowing When to Leave
42:09 - Final Reflections

---

RESOURCES

Annie Duke
https://www.annieduke.com/

Aristotle’s 10 Rules for a Good Life
https://www.theatlantic.com/ideas/archive/2023/08/aristotle-10-rules-happy-life/674905/

Personal Productivity: How to work effectively and calmly in the midst of chaos
https://www.cvdtraining.pitt.edu/wp-content/uploads/2023/01/Johnson2009_Essays.pdf

Understanding Academic Medical Centers: Simone’s Maxims
https://aacrjournals.org/clincancerres/article/5/9/2281/287826/Understanding-Academic-Medical-Centers-Simone-s

---

SYNPOSIS

They walk through the evidence driving the updates, including revised risk stratification and the expanding role of urinary biomarkers. The conversation highlights how these recommendations affect patient evaluation, imaging decisions, and shared decision-making, with an emphasis on balancing cancer detection, patient burden, and responsible use of healthcare resources.

---

TIMESTAMPS

00:00 - Introduction
01:33 - What Prompted the Guidelines Update?
02:59 - Challenges of a Negative Microhematuria Evaluation
06:21 - Initial Evaluation Guidelines
07:58 - Risk Stratification
18:11 - Imaging in Hematuria Workups
21:16 - Use of Urinary Biomarkers
33:25 - Potential Future Guideline Updates
37:17 - Takeaways for Urologists

---

RESOURCES

AUA/SUFU Microhematuria Guideline
https://www.auanet.org/guidelines-and-quality/guidelines/microhematuria

---

SYNPOSIS

They break down how global urology programs differ in structure, why cultural understanding is foundational, and what sustainable models look like in practice. The conversation highlights unmet reconstructive needs in low- and middle-income countries, evolving models for subspecialty development, and the growing role of long-term partnerships in shaping the future of global urology.

---

TIMESTAMPS

0:00 - Introduction
4:46 - Understanding Healthcare Systems Abroad
8:12 - Need for Global Urology
13:39 - Role of Reconstructive Urology Abroad
21:57 - Current Programs
27:20 - GU Impacts
39:35 - Building Capacity through Training
49:00 - Past Successes
58:38 - Future Directions
1:14:12 - Getting Involved

---

RESOURCES

GU Impacts
https://medicine.utah.edu/surgery/urology/gu-impacts

IVUMed
https://www.ivumed.org/

Urology Care Foundation
https://www.urologyhealth.org/humanitarianism

---

This podcast is supported by:

Veracyte
https://www.veracyte.com/decipher-bladder

---

SYNPOSIS

They discuss the limitations of traditional staging systems and how molecular subtyping is providing deeper insight into tumor biology, treatment response, and prognosis. Dr. Chu highlights where these classifiers can be integrated into real-world clinical decision-making today, where the evidence is still emerging, and which ongoing trials may define the next era of precision medicine in urologic oncology.

---

TIMESTAMPS

0:00 - Introduction
3:01 - Overview of Genomic Classifiers
9:34 - Risk Stratification
15:22 - Current Evidence for Genomic Classifiers
22:07 - Clinical Implications of Biomarkers
27:23 - Ordering Genomic Classifiers
33:46 - Future Directions
37:57 - Final Takeaways

---

RESOURCES

Alignment of molecular subtypes across multiple bladder cancer subtyping classifiers
https://pubmed.ncbi.nlm.nih.gov/38480079/

GUSTO Trial
https://fundingawards.nihr.ac.uk/award/NIHR128103

---

SYNPOSIS

The discussion highlights the power of mentorship, community, and transparency, especially for physicians balancing patient care and family life. From combo-feeding and night nannies to sleep deprivation, identity shifts, and the six-month reevaluation rule, both guests share wisdom they hope future trainees and new parents won't have to learn alone. This episode is a reminder that things get easier with time, that asking for help is strength, not weakness, and that paying it forward makes the path smoother for the next generation.

---

TIMESTAMPS

00:00 - Introduction
03:07 - Support Systems, Mentorship and Maternity Leave
09:03 - Navigating Lactation and Pumping
19:21 - Lactation Resources
25:58 - Finding Your Village and Outsourcing Tasks
34:31 - Balancing Parenthood and Career
42:26 - Sleep Deprivation and Protecting Your Schedule
55:14 - Maintaining Spousal Relationships
59:20 - Rebuilding Your Practice Post-Maternity Leave
01:03:56 - Final Thoughts and Advice for New Parents

---

RESOURCES

Dr. MILK (Mothers Interested in Lactation Knowledge) Support Group
https://www.drmilk.org/

---

SYNPOSIS

Dr. Tan shares practical, evidence-based strategies for improving decision-making conversations, from clearer framing to simple visual aids that reduce anxiety. They discuss how patients often perceive much greater risk of metastasis than what data shows, and why “turning down the temperature” is essential before discussing options. They also touch on evolving tools, including AI, that may improve how clinicians communicate risk and support patients through uncertainty.

---

TIMESTAMPS

00:00 - Introduction
01:02 - Journey to Decision Science
05:59 - Research on Decision Making
14:41 - Shared Decision Making in Practice
22:39 - Resources for Shared Decision Making
39:54 - Improving Decision-Making Conversations

---

RESOURCES

Decisional conflict among patients newly diagnosed with clinical T1 renal masses: a prospective study
https://pmc.ncbi.nlm.nih.gov/articles/PMC11233232/

Decisional Quality in Patients With Small Renal Masses
https://pubmed.ncbi.nlm.nih.gov/29574123/

Impact of renal mass biopsy on decision-making experience for clinical T1 renal masses
https://pubmed.ncbi.nlm.nih.gov/41151063/

MUSIC Patient and Provider Resources for Shared Decision Making
https://musicurology.com/programs/kidney/

P3P - Prostate Cancer Shared Decision Making Resource
https://www.p3p4me.org/users/login

Best Case/Worst Case Treatment Decision Tool
https://patientpreferences.org/best-case-worst-case/

Better Conversations Treatment Decision Tool
https://patientpreferences.org/better-conversations/

---

This podcast is supported by:
Ferring Pharmaceuticals

---

SYNPOSIS

The doctors discuss complex bladder cancer cases, sequencing treatments for patients with dual ureteral and bladder T1 disease, the impact of cystectomy on quality of life, and the use of blue light cystoscopy and intravesical therapy. They also delve into the rise of bladder cancer in younger patients, considerations for low-grade intermediate-risk disease, and emerging therapeutic options.

---

TIMESTAMPS

00:00 - Introduction
05:52 - Upper Tract Positive Cytology Dilemma
09:10 - Cystectomy Considerations
15:55 - Developing Better Patient-Reported Outcomes
20:26 - Challenges with New Therapeutics
26:31 - Deescalating Treatment for Low-Grade Cancer
33:29 - Closing Remarks

---

RESOURCES

CISTO Trial
https://pubmed.ncbi.nlm.nih.gov/37980511/

---

SYNPOSIS

They discuss the scope of OR-generated waste, the impact of plastics and carbon emissions, and emerging data linking environmental exposures to carcinogenesis. Dr. Patel highlights evidence supporting reusable vs. single-use instruments, shares examples of successful waste-reduction initiatives, and emphasizes the importance of cross-disciplinary collaboration to make sustainable practices achievable across healthcare systems.

---

TIMESTAMPS

0:00 - Introduction
3:29 - Current State of OR Waste
20:09 - Strategies to Reduce Waste
24:52 - Impact of Climate Change on Patients
33:55 - Future Directions
40:27 - Conclusion

---

This podcast is supported by:
Ferring Pharmaceuticals

---

SYNPOSIS

The doctors share treatment strategies, staging processes, and post-therapy patient management techniques. They address recurrent disease, approaches to different stages of cancer, the role of biomarkers in determining treatment paths, and considerations for both high-risk and intermediate-risk patients. Additionally, the episode touches on new treatments, clinical trials, and patient quality of life post-treatment.

---

TIMESTAMPS

00:00 - Introduction
02:08 - Case Study: Initial Patient Assessment
04:59 - Surgical Considerations and Techniques
10:22 - Managing Bladder Cancer Recurrence
11:15 - Treatment Options and Clinical Trials
15:12 - Advanced Treatment Strategies
28:14 - Closing Remarks and Credits

---

RESOURCES

VISTA Trial https://abstracts.mirrorsmed.org/abstracts/vista-phase-3-trial-vicinium-epcam-targeted-pseudomonas-exotoxin-bcg-unresponsive-non

BRIDGE Trial
https://pmc.ncbi.nlm.nih.gov/articles/PMC10515442/

CORE-008 Trial
https://www.sciencedirect.com/science/article/abs/pii/S1078143924010147

GAIN Trial
https://pmc.ncbi.nlm.nih.gov/articles/PMC10176900/

---

SYNPOSIS

The conversation explores the broader future of bladder transplant surgery, from ethical considerations to the potential for merging bladder transplantation with tolerance-induction protocols that could one day eliminate the need for lifelong immunosuppression. Dr. Nassiri reflects on the importance of patient-first decision-making, teamwork, and careful innovation as the field moves toward new possibilities in restorative urology and transplant medicine.

---

TIMESTAMPS

00:00 - Introduction
02:51 - The Path to Bladder Transplant Surgery
05:00 - Scientific Challenges and Barriers
06:45 - Patient Selection and Initial Outcomes
12:28 - Quality of Life Considerations
14:18 - Performing the First Bladder Transplant
18:59 - Donor Matching
21:28 - Ethical Considerations
24:51 - Research Gaps and Future Prospects

---

RESOURCES

Clinical Trial: Vascularized Composite Bladder Allograft Transplantation
https://www.clinicaltrials.gov/study/NCT05462561

Clinical Trial: Retro-active Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-identical Kidney Transplants
https://clinicaltrials.gov/study/NCT05525507

---

This podcast is supported by:
Ferring Pharmaceuticals

---

SYNPOSIS

Donahue and Moore share their experiences with intravesical therapy, discussing practical issues such as patient management, scheduling, and handling side effects. They emphasize the importance of creating a supportive environment in clinics, proactive treatment plans, and ensuring effective communication among the multidisciplinary team. They also share resources and tips for nurses and nurse practitioners new to urologic oncology.

---

TIMESTAMPS

00:00 - Introduction
07:09 - Multidisciplinary Team Dynamics
11:34 - Resources for Patients
18:55 - Transvaginal Estrogen Cream
26:56 - Optimizing Intravesical Therapy Clinics
35:57 - The Importance of Multidisciplinary Collaboration
36:27 - Conclusion

---

SYNPOSIS

They discuss advances in surgical techniques like skin-sparing debridement and the value of high-volume centers for patient outcomes. They also explore the use of wound vacuums, the challenges related to testicular management, and the future of Fournier’s gangrene treatment, including early detection and better patient scoring systems.

---

TIMESTAMPS

0:00 - Introduction
3:04 - Evolution of Fournier’s Management
7:50 - Management at High-Volume vs. Community Centers
20:39 - Use of Wound Vacs
27:03 - Testicular Management
43:56 - Future Directions

---

This podcast is supported by:
Ferring Pharmaceuticals

---

SYNPOSIS

The conversation covers the current challenges of interpreting positive biomarkers without clinical correlates, the gold standard of biopsies, and the potential of various biomarkers such as urine cytology, FISH, and newer genomic tests like the Decipher Bladder Genomic Classifier. They also touch upon the role of AI in pathology, the cost implications of biomarkers, and how these tools might influence future clinical practices and patient decisions. The episode emphasizes the need for precision medicine, careful patient counseling, and the impact of false positives and negatives on both patients and healthcare providers.

---

TIMESTAMPS

00:00 - Introduction
05:25 - Challenges with Current Biomarkers
08:10 - New Biomarkers and Genomic Classifiers
21:10 - AI and Pathology in Bladder Cancer
35:13 - Screening and Future Directions
41:20 - Challenges and Future Directions in Bladder Cancer Surveillance
57:51 - Conclusion

---

RESOURCES

DaBlaCa-15 Trial
https://pubmed.ncbi.nlm.nih.gov/40280776/

Sam Chang CHAI Study
https://pubmed.ncbi.nlm.nih.gov/40514253/

---

This podcast is supported by:
Ferring Pharmaceuticals

---

SYNPOSIS

The conversation covers the efficacy and safety of checkpoint inhibitors like pembrolizumab, the importance of a multidisciplinary approach, and the challenges of balancing systemic and localized treatments. They also touch upon the potential future role of biomarkers in reducing invasive procedures and improving patient outcomes.

---

TIMESTAMPS

00:00 - Introduction
02:04 - The Role of Medical Oncologists in Bladder Cancer
12:58 - Combination Therapies and Patient Outcomes
21:18 - The CREST Study
26:59 - Managing Adverse Events
34:44 - Collaboration Between Urologists and Oncologists
41:06 - Conclusion and Final Thoughts

---

RESOURCES

CREST Trial
https://www.nature.com/articles/s41591-025-03738-z

CISTO Study
https://pubmed.ncbi.nlm.nih.gov/37980511/

---

This podcast is supported by:
Ferring Pharmaceuticals

---

SYNPOSIS

The discussion delves into the newest treatment strategies and FDA-approved therapies for non-muscle invasive bladder cancer with an emphasis on BCG-refractory patients. They highlight their approaches to sequencing therapies, the real-world applicability of these treatments, and the impact of patient factors in clinical decision-making. The panel also explores emerging trials and innovative treatment mechanisms, emphasizing the importance of personalized care in oncology.

---

TIMESTAMPS

00:00 - Introduction
05:09 - Challenges and Strategies in Treatment
10:55 - Bladder Sparing Therapies
21:41 - Practical Tips for Therapy Administration
30:39 - Challenges and Considerations in Reinduction
37:05 - Clinical Trials and Future Directions
44:11 - Counseling Patients on Treatment Options
57:36 - Concluding Thoughts and Future Outlook

---

RESOURCES

CORE-008 Clinical Trial
https://www.sciencedirect.com/science/article/abs/pii/S1078143924010147

Legend Clinical Trial:
https://ascopubs.org/doi/10.1200/JCO.2025.43.5_suppl.802

CISTO Study
https://pubmed.ncbi.nlm.nih.gov/37980511/

---

This podcast is supported by:
Ferring Pharmaceuticals

---

SYNPOSIS

The conversation covers initial patient consultations, discussing diagnoses, personalized treatment options such as BCG, gemcitabine, clinical trials, and managing side effects. The experts emphasize the importance of clear communication, understanding patient preferences, and tailoring approaches to enhance the patient's quality of life. They also explore insights from recent studies like the CISTO trial and highlight novel research directions.

---

TIMESTAMPS

00:00 - Introduction
04:28 - Counseling Patients on Diagnostic Findings
12:03 - Symptom Management and Patient Care
19:30 - Post-Procedure Care and Counseling
28:50 - Recovery After TURBT: Medications and Patient Care
44:16 - The Impact of Radical Cystectomy on Quality of Life
49:15 - Final Thoughts and Future Directions in Bladder Cancer Care

---

RESOURCES

NIMBUS Study
https://pubmed.ncbi.nlm.nih.gov/32446864/

---

This podcast is supported by:

Ferring Pharmaceuticals

---

SYNPOSIS

The doctors emphasize the importance of having an experienced cytopathologist and discuss the use of different biomarkers and imaging modalities in bladder cancer diagnosis. The conversation delves into risk stratification, patient management strategies, and the evolving role of technology and artificial intelligence in enhancing diagnostic accuracy. The experts also share their perspectives on future advancements and their potential impact on clinical practice.

---

TIMESTAMPS

00:00 - Introduction
04:05 - Surveillance and Follow-Up Strategies
10:10 - Biomarkers in Bladder Cancer
18:02 - Blue Light Cystoscopy and Patient Comfort
30:56 - Risk Assessment and Counseling
42:56 - Future of Bladder Cancer Diagnostics
47:00 - Concluding Thoughts

---

RESOURCES

CxBladder Study
https://www.sciencedirect.com/science/article/pii/S1078143923000091

Lars Dyrsakjot Study on Tumor Markers
https://pmc.ncbi.nlm.nih.gov/articles/PMC7690647/

The Bridge Trial
https://pmc.ncbi.nlm.nih.gov/articles/PMC10515442/

---

This podcast is supported by:

Ferring Pharmaceuticals
---

SYNPOSIS

The conversation covers diagnostic dilemmas, navigating the treatment options of surgery, systemic therapy, and radiation, and the importance of a multidisciplinary approach. Through detailed case reviews, the panel highlights practical pearls, emerging clinical trials, and collaborative approaches that exemplify modern kidney cancer care.

---

TIMESTAMPS

0:00 - Introduction
02:20 - Case 1 (Incidental Renal Mass)
16:52 - Case 2 (Bilateral Renal Masses)
37:22 - Case 3 (Locally Advanced Renal Mass)
56:34 - Case 4 (Symptomatic, Metastatic Disease)
01:14:00 - Final Takeaways

---

This podcast is supported by:
Ferring Pharmaceuticals

---

SYNPOSIS

The multidisciplinary discussion addresses clinical decision-making in active surveillance versus early intervention, the role of PSMA PET imaging in detection and treatment planning, and evolving strategies for metastatic and castration-resistant disease. They also evaluate the therapeutic potential of alpha emitters and radioligand therapies, consider the evidence behind treatment intensification and de-intensification, and explore how these approaches can be individualized to optimize patient outcomes.

---

TIMESTAMPS

0:00 - Introduction
1:48 - Active Surveillance in Low-Risk Prostate Cancer
7:08 - Molecular Testing and Risk Stratification
8:28 - Radiation Therapy Approaches
20:16 - PSA Recurrence and PSMA PET Scans
32:40 - The Role of ADT
37:15 - PSMA PET Scans
40:58 - Genetic Testing in High-Risk and Metastatic Prostate Cancer
46:54 - Treatment Intensification vs. De-Intensification Trials
55:59 - Castration-Resistant Prostate Cancer

---

This podcast is supported by:

Ferring Pharmaceuticals

---

SYNPOSIS

Dr. Pieretti and Dr. Silva discuss how ctDNA can refine staging, identify patients at risk of recurrence, and guide decisions on when to intensify treatment. The conversation also examines its potential to detect actionable mutations, inform precision therapies, and shape the design of future clinical trials in urologic oncology.

---

TIMESTAMPS

0:00 - Introduction
2:50 - Overview of Bladder Cancer
12:59 - Overview of ctDNA
20:34 - Current ctDNA Trials
27:21 - Clinical Implications of ctDNA
31:20 - Conclusion

---

RESOURCES

Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma - PubMed
https://pubmed.ncbi.nlm.nih.gov/37500339/

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer | New England Journal of Medicine
https://www.nejm.org/doi/abs/10.1056/NEJMoa2408154

---

This podcast is supported by:

⁠Ferring Pharmaceuticals⁠

---

SYNPOSIS

Dr. Van Kuiken and Dr. Hampson explain the basics of imposter syndrome, its prevalence, and the many ways it can show up in medical training and practice. They also share candid personal experiences and practical strategies for overcoming self-doubt, from reframing negative thoughts to embracing feedback as a tool for growth. The doctors highlight the value of mentorship, peer support, and celebrating achievements, as well as the importance of creating a culture where vulnerability and open conversations are encouraged.

---

TIMESTAMPS

00:00 - Introduction
02:29 - Defining Imposter Syndrome
04:24 - Personal Experiences with Imposter Syndrome
08:44 - Impact of Imposter Syndrome in Medicine
10:39 - Strategies to Overcome Imposter Syndrome
13:59 - The Role of Mentorship
16:28 - Gender and Mentorship in Medicine
27:24 - Peer Support and Building Community
32:13 - Final Thoughts and Takeaways

---

RESOURCES

Medical Trainees and the Dunning–Kruger Effect: When They Don't Know What They Don't Know:
https://doi.org/10.4300/JGME-D-20-00134.1

Imposter Syndrome in Surgical Trainees: Clance Imposter Phenomenon Scale Assessment in General Surgery Residents:
https://doi.org/10.1016/j.jamcollsurg.2021.07.681

Defining the Incidence of the Impostor Phenomenon in Academic Plastic Surgery: A Multi-Institutional Survey Study:
https://doi.org/10.1097/prs.0000000000010821

Academic Urology Endowments and Leadership Roles are Disproportionately Held by Male Urologists:
https://doi.org/10.1016/j.urology.2025.04.038

Implementation of a “Best Self” Exercise to Decrease Imposter Phenomenon in Residents:
https://doi.org/10.4300/JGME-D-23-00873.1

Keep-Stop-Start Framework:
https://meded.ucsf.edu/sites/meded.ucsf.edu/files/2024-06/TipSheet-Feedback.pdf

Lean In:
https://leanin.org/

W. Brad Johnson, PhD:
https://www.wbradjohnson.com/

---

This podcast is supported by an educational grant from UroGen Pharma. UGN-102 was approved by the FDA on June 12, 2025.

---

SYNPOSIS

Dr. Luckenbaugh and Dr. Talwar delve into the history and significance of BCG in bladder cancer treatment, exploring the reasons behind the shortages and discussing various coping strategies, including split dosing and alternative intravesical therapies like gemcitabine, docetaxel, and the new mitomycin hydrogel. The conversation also covers emerging treatments for high-risk patients, the role of radical cystectomy, and the importance of standardization and innovation in dealing with medication shortages. Dr. Luckenbaugh highlights the importance of patient quality of life, cost considerations, and the need for resilient pharmaceutical supply chains.

---

TIMESTAMPS

00:00 - Introduction
01:56 - History and Importance of BCG in Bladder Cancer
03:21 - Challenges and Shortages of BCG
06:36 - Managing BCG Shortages in Clinical Practice
12:33 - New Alternatives and Treatments for Bladder Cancer
23:28 - The Role of Cystectomy in Bladder Cancer Treatment
26:12 - Future Directions and Final Thoughts

---

RESOURCES

BCG Shortage AUA Recommendations:
https://www.auanet.org/about-us/bcg-shortage-info

Reduced-dose bacillus Calmette-Guérin (BCG) in an era of BCG shortage: real-world experience from a tertiary cancer centre: https://pmc.ncbi.nlm.nih.gov/articles/PMC11951178/

Bladder Cancer Advocacy Network (BCAN):
https://bcan.org/

Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer With UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION)
https://pubmed.ncbi.nlm.nih.gov/39446087/b

FDA Approves Intravesical Mitomycin in Non–Muscle-Invasive Bladder Cancer:
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-mitomycin-intravesical-solution-recurrent-low-grade-intermediate-risk-non-muscle

TAR-200 - SunRISe-3 Study:
https://www.jnjmedicalconnect.com/products/tar-200/medical-content/tar-200-sunrise-3-study

First results from TAR-200 - SunRISe-1 Study:
https://www.jnj.com/media-center/press-releases/johnson-johnsons-tar-200-monotherapy-achieves-high-disease-free-survival-of-more-than-80-percent-in-bcg-unresponsive-high-risk-papillary-nmibc
N-803 Plus BCG Treatment for BCG-Naïve or -Unresponsive Non-Muscle

Invasive Bladder Cancer: A Plain Language Review:
https://pmc.ncbi.nlm.nih.gov/articles/PMC11524197/

---

SYNPOSIS

The discussion covers the significance of whole-person care in surgery and the critical role of empathy in surgical practice. Dr. Wright shares her experiences from her extensive career and research, including her innovative work in hip arthroscopy and advocacy for performance-based care for middle-aged patients. The surgeons also explore the impact of hormonal health on physical performance and quality of life, the value of tailored exercise and nutrition plans, and practical strategies for optimizing long-term vitality in both men and women. Dr. Wright emphasizes the need for healthcare professionals to lead by example in prioritizing their own well-being while staying informed on emerging science that supports longevity and quality of life.

---

TIMESTAMPS

00:00 - Introduction
13:50 - Urology Applications in Orthopedics
24:18 - Optimizing Longevity and Lifestyle
29:08 - Musculoskeletal Syndrome of Menopause
42:12 - Approach to Protein Intake and Supplements
50:48 - Practicing Longevity Medicine
53:26 - Final Thoughts

---

RESOURCES

Unbreakable: A Woman’s Guide to Aging with Power by Dr. Vonda Wright:
https://www.drvondawright.com/resources/books/unbreakable

---

SYNPOSIS

The conversation covers the importance of low-dose vaginal estrogen in treating genitourinary syndrome of menopause (GSM), the fear surrounding hormone therapy due to misinterpreted data from the Women's Health Initiative (WHI) study, and the inequities faced in women's health, particularly in the context of hormone replacement therapies. They discuss the legislative and advocacy strategies needed to enact change, emphasizing the role of professional societies, legislative efforts, patient advocacy, and industry support in overcoming the barriers to updating the black box warning.

---

TIMESTAMPS

00:00 - Introduction
03:43 - History Behind the Estradiol Black Box Warning
13:44 - The FDA Citizen Petition
18:18 - Gender Inequity in Medicine
24:05 - The Role of Organizational Guidelines in Patient Advocacy
28:51 - Vaginal Estrogen for Genitourinary Syndrome of Menopause (GSM)
32:57 - Medicare Spending and Legislative Advocacy
44:56 - Recap and Future Directions

---

RESOURCES

(TRAVERSE Trial) Cardiovascular Safety of Testosterone-Replacement Therapy
https://www.nejm.org/doi/full/10.1056/NEJMoa2215025

Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study
https://doi.org/10.1093/jnci/djac112

(ASCO Study) Use of local estrogen therapy among breast cancer patients in SEER-MHOS database
https://doi.org/10.1200/JCO.2025.43.16_suppl.578

Vaginal estrogen use in breast cancer survivors: a systematic review and meta-analysis of recurrence and mortality risks
https://doi.org/10.1016/j.ajog.2024.10.054

---

SYNPOSIS

Dr. Morgentaler shares insights from his decades-long career, including his pivotal research that refuted the presumed harms of testosterone therapy and belief that it contributes to the development of prostate cancer. The conversation explores the evolution of testosterone therapy, its misunderstood role in prostate cancer, and the need for broader clinical recognition of testosterone deficiency. The discussion also explores potential future applications of testosterone therapy, including its role in perioperative optimization and the growing need for nuanced, evidence-based guidelines in men’s health care.

---

TIMESTAMPS

00:00 - Introduction
08:45 - The Evolution of Testosterone Therapy
20:10 - Challenging Conventional Wisdom on Testosterone
34:04 - Reevaluating Testosterone and Prostate Cancer
51:20 - Testosterone and Prostate Cancer Recurrence
55:44 - Managing Testosterone Therapy in Prostate Cancer Patients
01:12:45 - Final Thoughts

---

RESOURCES

The Sex Doctors:
https://www.amazon.com/The-Sex-Doctors/dp/B0DCJQ5B5Q

---

SYNPOSIS

The episode covers how palliative care can improve quality of life for patients with serious illnesses, the challenges and opportunities of integrating palliative care into urology practice, and specific training resources and frameworks for effective communication and symptom management. From addressing common misconceptions to providing practical advice on implementing palliative care, this episode is an essential guide for trainees and urology professionals looking to deepen their understanding of palliative care and enhance their practice.

---

TIMESTAMPS

00:00 - Introduction
03:04 - Understanding Palliative Care
04:43 - Misconceptions and Communication Strategies
07:45 - Integrating Palliative Care in Urology
10:26 - Collaborative Approaches and Multidisciplinary Teams
15:48 - Training and Education for Trainees
20:25 - Effective Communication Techniques
28:18 - Impact of Palliative Care
34:33 - Final Thoughts and Takeaways

---

RESOURCES

Center to Advance Palliative Care website:
https://www.capc.org/

AUA White Paper:
https://www.auanet.org/documents/guidelines/white%20papers/postoperative.pdf

VitalTalk:
https://www.vitaltalk.org/

Eliciting the Patient’s Agenda- Secondary Analysis of Recorded Clinical Encounters:
https://link.springer.com/article/10.1007/s11606-018-4540-5

Family Meetings on Behalf of Patients with Serious Illness:
https://www.nejm.org/doi/full/10.1056/NEJMvcm1913056

---

SYNPOSIS

The conversation explores the transition from transrectal to transperineal prostate biopsy, emphasizing the role of PSA density and modern imaging in refining patient selection. Dr. Sánchez-Ortiz highlights the value of biomarkers in improving diagnostic accuracy and focal therapy as a promising, less invasive treatment option.
Beyond clinical innovations, the doctors also discuss the importance of communication in urology practice. Dr. Sánchez-Ortiz shares how tools like WellPrept can enhance patient education and engagement, reinforcing the need for individualized care strategies in an increasingly complex diagnostic landscape.

---

TIMESTAMPS

00:00 - Introduction
02:14 - Evolution of Prostate Biopsy Methods
17:51 - Transperineal vs. Transrectal Approaches
22:52 - Use of Sedation
35:10 - PSA Screening
41:48 - Rise in Metastatic Prostate Cancer
50:44 - Potential of Focal Ablation
55:58 - Use of WellPrept

---

RESOURCES

WellPrept:
https://www.wellprept.com/

---

SYNPOSIS

Dr. Iluyomade shares his preventive cardiology workup, the significance of lipid panels, and advanced diagnostics. They also explore the effects of common cardiovascular medications like beta blockers on sexual health and address common concerns related to testosterone and hormone therapies in both men and women. The conversation underscores the importance of interdisciplinary collaboration between urology and cardiology for optimal outcomes in patients with sexual dysfunction.

---

TIMESTAMPS

00:00 - Introduction
01:52 - The Intersection of Cardiology and Urology
03:43 - Understanding Preventive Cardiology
07:56 - Patient Risk Stratification and Workup
16:35 - Cardiovascular Health in Women
20:07 - Testosterone Therapy and Cardiovascular Risk
26:39 - Hormone Replacement Therapy in Men and Women
36:09 - Beta Blockers and Sexual Dysfunction
42:36 - Diuretics and Sexual Health
48:57 - A Message to Urologists from a Cardiologist

---

RESOURCES
TRAVERSE Trial Results: https://www.nejm.org/doi/full/10.1056/NEJMoa2215025

---

SYNPOSIS

Dr. Casperson breaks down the differences between the hormones used in WHI and the safer, more targeted options available today. The conversation explores the broad benefits of modern HRT, including reduced risks of cardiovascular disease, osteoporosis-related fractures, and even dementia. Beyond the science, the episode also addresses the urgent need for better medical education and updated guidelines around menopause care.
Dr. Casperson and Dr. Sutherland make the case for empowering patients through informed consent and better clinician training. They also discuss Dr. Casperson’s upcoming book, The Menopause Moment, which aims to equip women with the tools and knowledge to navigate this life stage with confidence.

---

TIMESTAMPS

00:00 - Introduction
02:50 - Focus on Menopause and Hormone Replacement Therapy
04:20 - The Women's Health Initiative (WHI) Study
05:39 - Understanding Risks and Misconceptions
12:43 - Reevaluation of the Women’s Health Initiative Study
18:31 - Impact of Media and Physician Education
19:58 - Current State of Hormone Therapy
22:17 - Broader Implications and Future Directions
27:17 - Evaluating FDA Warnings and Gender Bias in Hormone Treatments
29:49 - The Impact of Hormone Therapy on Women's Health
32:11 - Risks of Not Using Hormones
35:44 - Hormones and Brain Health: Debunking Myths
40:41 - The Timing Hypothesis and Long-Term Hormone Use
46:32 - Advocacy and Education for Menopause Awareness
48:04 - Conclusion and Upcoming Resources

---

RESOURCES

PBS: The M Factor: Shredding the Silence on Menopause:
https://www.pbs.org/show/the-m-factor-shredding-the-silence-on-menopause/

The Menopause Moment by Dr. Kelly Casperson: https://kellycaspersonmd.com/the-menopause-moment-book/

Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer's disease and dementia:
https://pmc.ncbi.nlm.nih.gov/articles/PMC10625913/

---

This podcast is supported by an educational grant from UroGen Pharma. UGN-102 was approved by the FDA on June 12, 2025.

---

SYNPOSIS

The doctors break down the nuances of defining this risk category and the clinical gray zones that complicate treatment decisions. Dr. Herrell shares her patient-centered approach to surveillance and therapy, and introduces promising new agents, including Anktiva, UGN-102, and the gemcitabine-releasing TAR-200 "pretzel" device. The discussion also highlights how advances in molecular profiling are reshaping care strategies.
This episode underscores the urgent need for clearer guidelines and continued innovation to improve outcomes and quality of life for patients with this nuanced disease subtype.

---

TIMESTAMPS

00:00 - Introduction
02:03 - Defining Intermediate Risk Bladder Cancer
06:12 - Intravesical Therapy Options
08:47 - Quality of Life and Patient Counseling
10:18 - New Treatments on the Horizon
12:56 - Practical Tips for TURBT Recovery
17:03 - In-Office Procedure Management
21:38 - Managing Symptoms and Quality of Life
31:50 - A Note on Smoking Cessation
33:37 - Conclusion and Future Directions

---

SYNPOSIS

The discussion covers the origins and evolution of their missions, the preparation required for high-volume surgical trips, and the clinical impact on both patients and participating healthcare providers. Dr. Peters and Dr. Hiller detail the logistical and financial hurdles involved, the emphasis on sustainable care models, and their strategies for fundraising. They also emphasize the value of cultural immersion and the long-term goal of establishing educational and medical infrastructure within the communities they serve.

---

TIMESTAMPS

00:00 - Introduction
01:23 - The Mission to Africa: How It All Began
02:32 - Challenges and Logistics of Medical Missions
06:02 - Resident Involvement and Impact
09:10 - Preparation and Experiences in Africa
11:38 - Overcoming Obstacles: Supplies and Customs
19:18 - Types of Procedures and Medical Work in Africa
21:45 - Upgrading Equipment and Training Local Staff
28:28 - Daily Operations and Patient Management
31:00 - Post-Trip Activities and Community Engagement
34:26 - Funding and Sustainability Efforts
40:31 - Personal Reflections and Future Plans

---

This podcast is supported by an educational grant from UroGen Pharma. UGN-102 was approved by the FDA on June 12, 2025.

---

SYNPOSIS

They emphasize a shift toward patient-centered, less aggressive treatment strategies, highlighting the importance of quality of life in clinical decision-making. The discussion includes risk stratification, the use of intravesical gemcitabine, and ongoing clinical trials. Dr. Bree also offers actionable tips for optimizing patient preparation and recovery. This episode underscores the growing importance of listening to patient voices to shape future standards of care.

---

TIMESTAMPS

00:00 - Introduction and Overview
02:09 - Risk Stratification and Treatment Approaches
06:12 - Intravesical Therapy Options
08:47 - Quality of Life and Patient Counseling
12:56 - Practical Tips for TURBT Recovery
17:03 - In-Office Procedures and Patient Management
21:23 - Resources and Support for Patients
24:13 - Future Directions and Final Thoughts

---

RESOURCES

Society of Urologic Oncology
https://suonet.org/home.aspx

---

SYNPOSIS

Dr. Andriole shares personal stories from his upbringing in Northeastern Pennsylvania and his journey into medicine. He reflects on his expedited education through Penn State and Jefferson Medical College and his path to urology. He discusses his pivotal work in prostate cancer screening, including the influence of major trials like The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, and traces the evolution of surgical and diagnostic techniques. The conversation also touches on current innovations and the future of prostate cancer management, offering valuable advice for the next generation of urologists.

---

TIMESTAMPS

00:00 - Introduction
01:59 - From Childhood to Medical School
06:48 - Discovering Urology
16:52 - Pioneering Prostate Cancer Screening
24:07 - The PLCO Study: Design and Challenges
28:57 - Controversies and Criticisms in Prostate Cancer Screening
33:29 - Evolving Practices in Prostate Cancer Management
44:19 - Future of Prostate Cancer Treatment

---

This podcast is supported by:
Ferring Pharmaceuticals

---

SYNPOSIS

This session covers case studies ranging from localized to advanced penile cancer, diagnostic practices, imaging preferences (MRI vs. CT), and treatment options, including surgery, brachytherapy, chemoradiation, and neoadjuvant chemotherapy. The multidisciplinary team highlights the complexities of treating this rare cancer, underscores the importance of physical exams, and stresses the necessity of personalized treatment plans. They also delve into the challenges of managing metastatic stages, potential salvage therapies, and the importance of clinical trials in enhancing treatment efficacy. The doctors also emphasize the potential of immunotherapy and chemotherapy combinations for metastatic disease.

---

TIMESTAMPS

00:00 - Introduction
02:23 - Imaging Preferences
03:29 - Biopsy vs Immediate Surgery
06:04 - Lymph Node Dissection vs Radiation
13:48 - Brachytherapy Techniques and Case Study
23:21 - Challenges in Advanced Penile Cancer
27:03 - Chemotherapy and Chemoradiation
30:15 - InPACT Trial
37:12 - Salvage Therapies and Exploring New Treatment Frontiers
44:25 - Support and Awareness for Penile Cancer
51:29 - Final Thoughts

---

RESOURCES

Society of Urologic Oncology
https://suonet.org/home.aspx

---

SYNPOSIS

The conversation covers daily tadalafil use, lifestyle optimization, and the nuanced role of off-label medications. Dr. Khera also highlights emerging technologies like the Tech Ring and radiofrequency treatments, alongside practical insights into semen analysis and hormonal health markers. Throughout, he emphasizes a holistic, patient-centered approach to sexual health—blending medical therapy with meaningful lifestyle change. This is a must-listen for general urologists, men’s health specialists, and trainees looking to expand their toolkit in this evolving field.

---

TIMESTAMPS

00:00 - Introduction
02:13 - Erectile Dysfunction and Testosterone
08:05 - Young Men's Health and Early Detection
10:20 - Semen Analysis for Overall Health
12:50 - Daily Tadalafil and Its Benefits
16:40 - Proactive Sexual Health Management
21:28 - Female Sexual Health
25:16 - Treating Delayed Ejaculation
28:53 - Psychogenic Erectile Dysfunction
31:16 - Technology in Sexual Health
35:54 - Lifestyle Modifications for Better Sexual Health
41:55 - Resources and Referrals for Patients
44:30 - Final Thoughts

---

This podcast is supported by:
Ferring Pharmaceuticals

---

SYNPOSIS

The discussion covers real-world UTUC cases, highlighting diagnostic challenges, treatment options, and evidence-based management strategies. They address scenarios ranging from localized to advanced UTUC, the role of systemic therapies, perioperative treatments, and the potential for novel approaches with immune checkpoint inhibitors. The episode underscores the evolving landscape of UTUC treatment and the importance of clinical trials and emerging biomarkers in improving patient outcomes.

---

TIMESTAMPS

00:00 - Introduction
02:49 - Case Study 1: 66-Year-Old Male with UTUC
11:19 - Case Study 2: 73-Year-Old Male with High-Grade Urothelial Carcinoma
28:11 - Intravesical Chemotherapy Protocols
30:44 - Case Study 3: 57-Year-Old Male with Recurrent Urothelial Cancer
41:25 Clinical Trials and Emerging Treatments
45:40 Case Study: 55-Year-Old Female with Bulky Lymphadenopathy
56:45 Concluding Remarks and Future Directions

---

RESOURCES

Society of Urologic Oncology
https://suonet.org/home.aspx

---

SYNPOSIS

This episode explores the benefits of single port (SP) robotic surgery, highlighting improved access, greater efficiency, and shorter patient recovery times. The doctors discuss the evolution of single port technology and the challenges that remain. They also share practical tips around case selection, building community support, and tracking outcomes to enhance efficacy. Whether you're new to SP or a seasoned surgeon, this episode offers valuable insights on how to refine your surgical practice.

---

TIMESTAMPS

00:00 - Introduction
04:18 - Early Adoption
06:50 - Commitment and Learning Curve
15:45 - Innovations and Best Practices
19:10 - The Magic of Single Port Access
29:29 - Practical Tips and Instrumentation
32:14 - Instrument Spread and Force Bipolar
34:25 - Benefits of Single-Port Surgery
35:57 - Challenges and Cognitive Load in SP Surgery
42:55 - Adoption and Resistance to SP Technology
50:52 - Final Thoughts

---

This podcast is supported by:
Ferring Pharmaceuticals

---

SYNPOSIS

They discuss the evidence-based use of complementary therapies alongside conventional cancer treatments, touching on various integrative methods including diet, exercise, mindfulness, acupuncture, yoga, and supplements. Dr. Master emphasizes the importance of physicians being open to these practices and understanding their potential benefits for improving patient outcomes and quality of life, even in highly acute cases like muscle-invasive bladder cancer. The conversation covers the importance of honesty and understanding across patient journeys–from initial diagnosis to survivorship–highlighting the value of holistic approaches in cancer care.

---
TIMESTAMPS
00:00 - Integrative Oncology: Definitions and Basics
06:28 - Exercise and Its Impact on Cancer Treatment
08:12 - Physician Perspectives on Complementary Medicine
20:58 - Acupuncture and Acupressure in Cancer Care
25:28 - Practical Implementation of Integrative Approaches
31:30 - Supplements and Immuno Nutrition
36:25 - Cannabis, CBD, and Ayurveda in Cancer Care
44:39 - Conclusion and Final Thoughts

---

RESOURCES

Society of Urologic Oncology
https://suonet.org/home.aspx

---

SYNPOSIS

The three leaders in academic urology cover essential topics such as choosing the right fellowship program, finding strong mentorship, and balancing personal and professional life. This episode also offers transparency into the application process. The conversation also delves into the nebulous differences between ACGME and non-ACGME fellowships. This episode is an excellent starting point for practical advice for residents considering this pivotal step in their urology careers.

---

TIMESTAMPS

00:00 - Introduction
03:07 - Differences Between Residency and Fellowship
07:02 - Building a Competitive Fellowship Application
11:09 - Pros and Cons of Pursuing a Fellowship
16:08 - Accredited vs. Non-Accredited Fellowships
20:30 - Choosing the Right Fellowship Program
27:31 - Importance of Fellowship Fit
28:46 - Evaluating Candidates Beyond Portfolios
30:03 - Letters of Recommendation
34:56 - Handling Fellowship Challenges
38:28 - Gender Diversity in Urology
43:31 - Balancing Family and Fellowship
50:09 - Concluding Thoughts

---

RESOURCES

Society of Women in Urology
https://swiu.org/home.aspx

---

SYNPOSIS

Together, they explore their unique, holistic approach to sexual medicine and metabolic health, combining hormone optimization, nutrition, and lifestyle modifications. They pay special attention to the difficult journey of perimenopause and its symptoms. The episode underscores the importance of thinking beyond conventional healthcare models and embracing comprehensive, personalized care. They also cover the successful integration of advanced technology and patient education. Finally, the conversation touches on self-care for healthcare providers to combat burnout and encourages medical professionals to develop a personal brand and diversify their professional activities.

---

TIMESTAMPS

00:00 - Introduction
07:10 - Addressing Hormonal Health in Men
08:53 - Nutrition and Weight Management
13:21 - Treating Perimenopause and Menopause
23:38 - The Importance of Hormone Replacement Therapy
30:45 - Weight Loss Beyond the Scale
32:05 - Importance of Muscle Maintenance
41:09 - Technology in Health Monitoring
49:03 - Daily Routines for Optimal Health
57:38 - Closing Thoughts on Holistic Health

---

RESOURCES

PRIME Institute:
https://www.primeinstitute.us/amy-pearlman-md/

---

SYNPOSIS

The discussion touches on mentorship, work-life balance, gender bias, and the importance of peer support community in predominantly male specialties. The episode highlights the impact of effective mentorship and the invaluable role of compassion in effective leadership.

---

TIMESTAMPS

00:00 - Introduction
03:00 - Women in Leadership
03:51 - The Importance of Mentors and Colleagues
05:49 - Challenges in Urology
07:57 - Balancing Career and Personal Life
29:55 - Navigating Gender Bias and Salary Disparities
36:43 - Final Reflections

---

RESOURCES

Society of Women in Urology
https://swiu.org/home.aspx

---

This podcast is supported by:

Ferring Pharmaceuticals

---

SYNPOSIS

The urologists discuss topics such as the experiences and benefits of interdisciplinary collaboration in complex cases and the role of pediatric urologists in treating adolescent and young adult patients. They also provide insights into the Children's Oncology Group (COG) studies and their intersections with adult oncology research. The episode concludes with practical advice for other institutions aiming to improve collaborative efforts between pediatric and adult urology departments.

---

TIMESTAMPS

00:00 - Introduction
02:35 - Challenges and Lessons in Multidisciplinary Collaboration
08:24 - Pediatric vs. Adult Urologic Oncology
11:07- Clinical Trials and Research Collaborations
12:49 - Navigating Oncology Groups for Children and Adults
19:06 - Collaborative Models in Kidney Cancer Care
22:18 - Benefits and Challenges of Collaboration
35:24 - Final Thoughts and Recommendations

---

RESOURCES

Society of Urologic Oncology:
https://suonet.org/home.aspx

Children’s Oncology Group
https://www.childrensoncologygroup.org/

---

SYNPOSIS

First, Dr. Mallow explains how she evaluates and treats patients. She discusses specific techniques, such as biofeedback, manual therapy, and therapeutic exercises like squats and lunges. Then, the experts underscore the significance of collaboration between urologists and physical therapists to provide comprehensive care for patients with pelvic floor disorders, bladder issues, and even post-prostatectomy rehabilitation. Dr. Pearlman also shares her tips to help urologists understand and utilize pelvic physical therapy more effectively.

---

TIMESTAMPS

00:00 - Introduction
02:43 - Understanding Pelvic Floor Physical Therapy
08:20 - Collaborative Approach to Treating Pelvic Health Issues
18:01 - Patient Education and Exercises
22:32 - Effective Cues for Post-Prostatectomy Patients
30:53 - Internal Exams and Patient Comfort
39:39 - Recommended Products for Pelvic Health
42:35 - Travel Tips for Pelvic Health

---

RESOURCES

Restore Pelvic Health & Rehab
https://restorepelvicrehab.com/

---

SYNPOSIS

Dr. Bennett discusses her impactful career and notable research in neuro-urology, including breakthroughs in electroejaculation for patients with spinal cord injury. Dr. Bennett also reflects on her experiences with mentorship from notable urologists, overcoming barriers, and the importance of perseverance. The discussion highlights her enduring dedication to the field and her role as an inspiration to trainees, colleagues, and patients.

---

TIMESTAMPS

00:00 - Introduction
04:27 - Choosing Urology
06:02 - Pioneering Research in Neuro-Urology
13:23 - Challenges and Mentorship
18:40 - Changes and Trends in Urology
23:01 - Work-Life Balance and Personal Insights
26:29 - Conclusion and Final Thoughts

---

RESOURCES

Society of Women in Urology
https://swiu.org/home.aspx

---

SYNPOSIS

The discussion begins with an emphasis on the significance of dietary fiber and protein in promoting digestive health, highlighting their role in preventing common gastrointestinal issues. Dr. Michelle then covers GLP-1 agonist medications like Ozempic and Wegovy, delving into their effects on weight management and outlining potential side effects that are relevant across both gastroenterology and urology.

Throughout the conversation, the sisters examine the interrelated nature of gastrointestinal and urinary conditions, emphasizing how thoughtful nutritional choices and regular exercise can support overall patient health. They also advocate for proactive management of constipation, especially after surgery. The episode concludes with practical resources that physicians can integrate into their practice to enhance patient care.

---

TIMESTAMPS

00:00 - Introduction
05:14 - GLP-1 Agonist Overview
10:55 - Muscle Mass and Sarcopenia
14:14 - Preventing Frailty: Hormones, Nutrition, and Exercise
21:23 - High-Quality Protein Options
24:42 - Inflammation, Gut Health, and Cancer Risk
34:34 - Post-Surgery Nutrition and Recovery
42:25 - Final Thoughts

---

RESOURCES

Prime Institute Miami:
https://www.primeinstitute.us/

---

SYNPOSIS

La conversación aborda las complejidades y desafíos en el tratamiento de la menopausia y la salud sexual de la mujer, incluyendo el uso de hormonas bioidénticas, testosterona y tratamientos personalizados. La Dra. Silén-Rivera destaca la importancia de la educación tanto para los profesionales médicos como para las pacientes, y habla sobre la necesidad de productos específicos para mujeres aprobados por la FDA. Además, discuten temas como las alternativas al reemplazo hormonal.

---

TIMESTAMPS

00:00 - Antecedentes y experiencia en salud sexual de la mujer

06:02 - Síntomas de la menopausia y enfoques de tratamiento

17:25 - Tratamiento personalizado y riesgos

29:23 - Terapia de reemplazo hormonal y anticonceptivos

33:00 - Terapia de testosterona en mujeres

43:45 - Educar a las futuras generaciones sobre la terapia hormonal

49:20 - La importancia del estrógeno vaginal

---

RESOURCES

Centro de Bienestar para la Mujer

https://www.centrobienestarmujer.com/

---

This podcast is supported by:

⁠⁠Ferring Pharmaceuticals⁠⁠

---

SYNPOSIS

The expert panel uses specific patient cases to review their decision-making processes on the use of surgery, chemotherapy, and radiation. They highlight the importance of a multidisciplinary approach, particularly for advanced disease and challenging surgical scenarios. The episode reviews patient-specific factors, standard treatment protocols, post-treatment surveillance, and the latest research. This episode also highlights the benefits of personalized cancer care.

---

TIMESTAMPS

00:00 - Introduction

01:45 - Case Presentation: 23-Year-Old Male with Testicular Mass

02:14 - Initial Counseling and Management

04:03 - Orchiectomy and Post-Surgery

06:27 - Stage I Management

10:00 - Surveillance and Adjuvant Therapy

13:56 - Recurrence

23:13 - Case Study: 44-Year-Old with Non-Seminoma

28:14 - Case Study: 17-Year-Old with Developmental Delay and Cancer

29:42 - Chemotherapy Decisions

30:31 - Brain Imaging and Metastasis Predictions

33:54 - Chemotherapy Regimens

35:53 - Monitoring and Salvage Therapy

45:01 - Case Study: 21-Year-Old with Teratoma

55:21 - Concluding Thoughts

---

RESOURCES

Society of Urologic Oncology:

https://suonet.org/home.aspx

---

SYNPOSIS

Dr. Clifton shares her journey evolving from surgery and clinical medicine to hospital administration, highlighting the importance of mentorship, skill-building, and strategic decision-making. She discusses her journey towards finding a balance between clinical practice and administrative roles. She also highlights the challenges and rewards of working in hospital leadership. This episode offers key guidance on obtaining mentorship, coaching, and executive presence. This candid conversation provides valuable insights for any physician interested in leadership roles.

---

TIMESTAMPS

00:00 - Introduction

02:28 - Dr. Marisa Clifton's Career Journey

13:03 - Balancing Clinical and Administrative Roles

17:01 - Challenges and Growth in Leadership

25:31 - Balancing Clinical Medicine and Hospital Administration

28:08 - Improving Communication Between Clinicians and Administrators

32:20 - Leadership Development

38:02 - The Role of Coaching

43:13 - Final Thoughts and Future Directions

---

RESOURCES

Society of Women in Urology

https://swiu.org/home.aspx

---

SYNPOSIS

Drawing from extensive studies and meta-analyses, Dr. Wallace highlights a significant mortality benefit for patients treated by female surgeons. The episode explores how these findings have sparked discussions on surgeon practices, patient care, and gender equity in medicine. Dr. Wallace also shares personal experiences to underline the importance of diversity and inclusive practices in healthcare. Finally, the two urologists discuss challenges faced when supporting diversity efforts and opportunities for future progress.

---

TIMESTAMPS

00:00 - Introduction

04:01 - Personal Experience with Gender Bias in Surgery

07:05 - Groundbreaking Data on Surgeon Sex and Patient Outcomes

12:23 - Long-Term Outcomes and Consistency in Data

14:14 - Hypotheses and Underlying Reasons for Better Outcomes with Female Surgeons

20:18 - Impact on Healthcare Costs and Productivity

26:14 - Challenges and Pushback in the Medical Community

35:05 - Conclusion

---

RESOURCES

Society of Women in Urology

https://swiu.org/home.aspx

---

SYNPOSIS

Dr. Patel details his journey from growing up in a small town in Arizona to becoming a successful urologist. He discusses the internal battles, external pressures, and pivotal moments that shaped his life and career. He then highlights the importance of peer support and introduces his new initiative, SafeHavenMD, a platform designed to provide confidential, peer-to-peer support for physicians dealing with mental health and substance abuse issues. This episode is a must-listen as it offers a raw and emotional insight into the often unseen challenges faced by medical professionals.

---

TIMESTAMPS

00:00 - Introduction

03:29 - Early Signs of Alcoholism

03:56 - Medical School and Escalating Alcohol Use

05:43 - Journey to Sobriety

08:26 - Creating SafeHavenMD

19:40 - Personal Experience and Resources

20:20 - Handling Complications and Peer Support

21:47 - SafeHavenMD: An Overview

23:05 - Monitoring Programs and Confidentiality

24:19 - Disclosing Issues and Seeking Help

34:11 - Closing Message to the Audience

---

SYNPOSIS

The discussion covers a broad spectrum of topics in the transition of pediatric urology patients to adult care. Key highlights include self-catheterization, testicular torsion, bladder augmentation, and patients with a history of pediatric surgeries or spina bifida. Dr. Mauck emphasizes a collaborative discussion on the importance of managing conditions independently versus seeking specialized help for these complex patient situations.

---

TIMESTAMPS

00:00 - Introduction

03:41 - Testicular Torsion Emergencies

08:45 - Common Challenges in Pediatric Urology

16:34 - Bladder Augmentation and Rupture

27:24 - Self-Catheterization

30:25 - Reflux and Reimplantation

35:25 - Managing Pediatric Urology Patients in Adulthood

46:47 - Outpatient Management of Reconstructed Bladders

50:58 - Embracing a Multidisciplinary Approach

54:02 - Key Takeaways

---

SYNPOSIS

Dr. Pearlman shares her journey from academic urology to healthcare entrepreneurship, emphasizing the personalized, holistic care offered at her practice. The conversation covers the procedure's impact on patients' lives, the management of a concierge clinic, and the integration of sexual health with overall wellness. Dr. Pearlman elaborates on the specifics of the penile girth enhancement procedure using hyaluronic acid. She covers patient experiences, consultation practices, and safety protocols. The episode emphasizes the broader conversation around men’s health and the importance of sexual well-being.

---

TIMESTAMPS

00:00 - Introduction

10:09 - Injectable vs. Surgical Options

10:30 - Hyaluronic Acid Fillers

14:06 - Patient Experiences and Expectations

24:09 - Injection Techniques and Aftercare

32:55 - Understanding Penile Aesthetics

35:43 - Consultation Process

37:23 - Pain Management

39:01 - Patient Experiences and Feedback

46:53 - Telehealth Consultations

49:22 - Closing Advice for Providers

---

This podcast is supported by:

Photocure

https://www.photocure.com/

---

SYNPOSIS

The conversation covers the challenging side effects of perioperative treatments, the evolution of therapies from tyrosine kinase inhibitors to modern checkpoint inhibitors, and the introduction of adjuvant therapies. Dr. Pal and Dr. Bagrodia explore the impact of these treatments on patient outcomes, the challenges with current biomarkers, and the potential of emerging trials. The doctors also highlight the importance of personalized RCC management strategies, particularly for high-risk patients and non-clear cell histologies. They also emphasize the need for appropriate patient counseling in this emerging field.

---

TIMESTAMPS

00:00 - Introduction

01:53 - Evolution of Kidney Cancer Treatments

03:30 - Tyrosine Kinase Inhibitors in the 2010s

10:42 - Checkpoint Inhibitor Trials

23:09 - Discussing Adjuvant Therapy with Patients

26:56 - Restaging and Biomarkers

31:58 - Challenges in Adjuvant Immunotherapy

39:57 - Non-Clear Cell RCC

41:42 - Future Directions

---

RESOURCES

Photocure:

https://www.photocure.com/

---

This podcast is supported by:

Photocure

https://www.photocure.com/

---

SYNPOSIS

First, the doctors cover a wide range of topics including PARP inhibitors for prostate cancer, HER2-targeting antibody drug conjugates in bladder cancer, adjuvant chemotherapy for upper tract urothelial carcinoma, and biomarkers such as KIM-1 in kidney cancer. Highlighting the importance of multidisciplinary collaboration, the experts also critique the COSMIC-313 trial and discuss the nuances of applying new therapeutic combinations in real-world clinical practice.

---

TIMESTAMPS

00:00 - Introduction

09:20 - TALAPRO-2 Trial Insights

19:29 - Bladder Cancer: Immuno-Oncology Combinations and HER2

27:42 - NIAGARA and iNDUCT Trials

33:32 - Future Directions in Upper Tract Treatment

37:38 - Biomarkers in Kidney Cancer: KIM-1

46:43 - COSMIC-313: Triplet Therapy in Renal Cell Carcinoma

52:39 - Concluding Thoughts and Future Directions

---

RESOURCES

Photocure:

https://www.photocure.com/

---

This podcast is supported by:

Photocure

https://www.photocure.com/

---

SYNPOSIS

Extended clinic exposure can facilitate better clinical decision-making, improve understanding of pathology, and help develop soft skills. Dr. Keenan shares her experience in implementing a longitudinal resident clinic (LRC) model at her institution, emphasizing its role in providing continuity and autonomy. As a senior resident, Dr. Koch reflects on his experiences from participating in the LRC, underlining its value in preparing for independent practice.

---

TIMESTAMPS

00:00 - Introduction

02:37 - Outpatient Resident Education

08:13 - Effective Teaching in Clinic

19:42 - Innovative Longitudinal Resident Clinic (LRC) Model

27:59 - Advice and Final Thoughts

---

RESOURCES

Photocure:

https://www.photocure.com/

---

SYNPOSIS

Dr. Ackerman and Dr. Sutherland talk through the challenges of diagnosing chronic UTI symptoms, the limitations of standard urine cultures, and the role of new, enhanced culture methods and molecular diagnostics. They emphasize the importance of clinical judgment, the potential misuse of antibiotics, and the need for a long-term approach to managing urinary symptoms while maintaining a healthy microbiome.

---

TIMESTAMPS

00:00 - Introduction

01:58 - The Bladder Microbiome

05:44 - Challenges in Diagnosing UTIs

16:36 - Enhanced Quantitative Urine Culture

21:30 - Molecular Diagnostic Approaches

34:01 - Chronic UTIs and Long-Term Management

46:10 - Conclusion

---

SYNPOSIS

The urologists discuss advantages and disadvantages of various BPH interventions, providing insight on when to use what. The conversation then goes deeper on holmium laser enucleation of the prostate (HoLEP), emphasizing the importance of appropriate patient counseling about retrograde ejaculation and transient urinary incontinence. Dr. El Tayeb shares his experiences in managing BPH both medically and surgically. He details his procedural approach, patient selection criteria, and postoperative care, along with special considerations for patients with prostate cancer on active surveillance. The episode concludes with a detailed look at alternative prostate treatments and insights into upcoming technological advancements in prostate care.

---

TIMESTAMPS

00:00 - Introduction

02:44 - Evolution of BPH Treatments

09:40 - Weighing BPH Procedures

14:33 - HoLEP Insights

20:59 - Understanding HoLEP Equipment

21:06 - Techniques for Intravesical Lobes

24:10 - Post-Procedure Decisions

30:33 - Special Considerations for Cancer Patients

40:24 - Alternative Treatments and Final Thoughts

---

This podcast is supported by:

Photocure

https://www.photocure.com/

---

SYNPOSIS

Dr. Dwyer shares her personal journey and residency experiences, focusing on the formalized research training that she received as a trainee. The conversation covers the benefits of conducting peer review for residents, how to get involved, and how peer review can enhance your clinical and academic career. They also discuss the potential of formalizing a trainee peer review system across institutions to ensure all residents have access to peer review opportunities. Finally, the doctors conclude by discussing the balance of clinical duties with academic endeavors and personal wellness during residency.

---

TIMESTAMPS

00:00 - Introduction

03:28 - Getting Started with Peer Review

08:50 - Tips for Effective Peer Review

19:03 - Formalizing Peer Review Programs

24:39 - Advice for Residents

---

RESOURCES

Photocure

https://www.photocure.com/

---

This podcast is supported by:

Boston Scientific UroAdvance

http://bostonscientific.com/uroadvance

---

SYNPOSIS

The doctors discuss key pillars to success as a physician couple, including flexibility, effective communication, and building a village of support. The conversation offers personal insights and strategies into managing childcare, household chores, and ensuring career fulfillment for both partners. The episode also emphasizes the need for further advocacy in the workplace, including parental leave policies.

---

TIMESTAMPS

00:00 - Introduction

02:09 - Life as a Dual Physician Couple

04:31 - Career Decisions and Relocation Challenges

06:34 - Financial Discussions

13:24 - Parental Leave and Childcare

19:59 - Early Morning Routine and Nannies

27:33 - Household Chores and Outsourcing

34:47 - Work-Life Balance and Integration

42:18 - Final Thoughts

---

RESOURCES

Boston Scientific

https://www.bostonscientific.com/en-US/medical-specialties/urology/products.html

Society of Women in Urology

https://swiu.org/home.aspx

---

This podcast is supported by:

Boston Scientific UroAdvance

http://bostonscientific.com/uroadvance

---

SYNPOSIS

The episode focuses on Dr. deVries experiences as a groundbreaking woman in the historically male-dominated field of urology. Dr. deVries delves into her landmark contributions to global health, particularly through her work leading IVUMed. She shares her experiences developing sustainable surgical care programs and her academic journey. The conversation also touches on the importance of ethics and public health when conducting surgical missions. The discussion serves as an inspiration for future generations in the field of urology and global health.

---

TIMESTAMPS

00:00 - Introduction

02:17 - Dr. DeVries' Academic and Professional Journey

04:08 - Experiences as a Woman in Urology

14:55 - Pediatric Urology and Global Health

21:54 - Founding IVUMed

40:34 - Future Directions

44:14 - Conclusion

---

RESOURCES

Boston Scientific

https://www.bostonscientific.com/en-US/medical-specialties/urology/products.html

Society of Women in Urology

https://swiu.org/home.aspx

---

This podcast is supported by:

Boston Scientific UroAdvance

http://bostonscientific.com/uroadvance

---

SYNPOSIS

The doctors talk about SWIU's rapid growth, its role in networking and career development for women, and its proven impact across career stages. They highlight the importance of the annual Clinical Mentoring Conference, which provides a unique opportunity for networking and professional development. The conversation also underscores SWIU's inclusivity and efforts for gender-diverse individuals. Looking ahead, Dr. Mehta and Dr. Thavaseelan predict continued growth, innovation, and deeper integration in organized urology.

---

TIMESTAMPS

00:00 - Introduction

02:42 - History of SWIU

03:29 - Personal Journeys with SWIU

07:08 - The Mentoring Conference

09:27 - Career Development

34:40 - Inclusivity and Male Allyship

39:14 - Conclusion

---

RESOURCES

Boston Scientific

https://www.bostonscientific.com/en-US/medical-specialties/urology/products.html

Society of Women in Urology

https://swiu.org/home.aspx

---

This podcast is supported by:

Photocure

https://www.photocure.com/

---

SYNPOSIS

The doctors offer a historical perspective into the evolution of ADT over time and discuss the variety of different ADT treatment options available. They compare management strategies for localized and metastatic prostate cancer and discuss how to align therapy with patient goals, focusing on the side effects. The conversation also explores the impact of prostate-specific membrane antigen (PSMA) PET imaging on management and the future directions of hormonal therapies in urologic oncology.

---

TIMESTAMPS

00:00 - Introduction

05:25 - ADT Options

10:36 - Choosing an Agent and Managing Side Effects

26:42 - Continuous Versus Intermittent Therapy

30:30 - Closing Remarks

---

RESOURCES

Photocure

https://www.photocure.com/

---

This podcast is supported by:

Ferring Pharmaceuticals

---

SYNPOSIS

The two urologic oncologists share their decision-making process for different therapies such as BCG, gemcitabine-doxorubicin, and Adstiladrin. The conversation also touches on the challenges of integrating new technologies into practice, managing the BCG shortage, and the role of multidisciplinary care. They discuss patient-centered care and the potential for personalized treatment plans. Finally, Dr. Jayram reflects on the lessons he has learned from his own practice, offering a unique insight into the differences between academic and community urology.

---

TIMESTAMPS

00:00 - Introduction

04:47 - Community Practice and New Technologies

09:59 - Clinical Trials for Bladder Cancer Care

15:52 - Patient Referrals

29:27 - Exploring New Treatment Options

30:46 - Bladder Sparing Strategies

32:21 - BCG Treatment and Surveillance

47:04 - Implementation of New Therapies

54:27 - Future Directions

---

RESOURCES

Ferring Pharmaceuticals

https://www.ferring.com/

---

This podcast is supported by:

Photocure

https://www.photocure.com/

---

SYNPOSIS

Their discussion highlights the rewarding experience in seeing patients throughout their treatment journey. Dr. Tatem, a men's health specialist with an extensive academic background, emphasizes the value of integrating APPs like Kristen into his practice. Kristen shares her journey, highlighting the importance of continuous learning. Both share their personal stories on the early days and evolution of their partnership. The conversation delves into the dynamics of their successful clinic model, the impact of their work on patient care, and their plans for expanding and educating within the field of men's health.

---

TIMESTAMPS

00:00 - Introduction

05:10 - Kristen's Path to Specialization

17:42 - Redefining Roles and Responsibilities

28:00 - Work-Life Balance

31:12 - Office Procedures

34:35 - Expanding the Team

47:26 - Team Dynamics

54:18 - Concluding Thoughts

---

RESOURCES

Dr. Alex Tatem’s practice website:

https://www.alextatemmd.com/

APP Fellowship Program in Indianapolis, Indiana:

https://menshealthin.com/training/

2024 Prosthetic Urology Institute: Advanced Practice Provider Preceptor Program - Kristen Gumpf, PA-C:

https://cvent.me/mNE3ly

2024 Prosthetic Urology Institute: Preceptor and Clinic Communications Program with Dr. Alex Tatem:

https://cvent.me/1ZKdEq

---

This podcast is supported by:

Photocure

https://www.photocure.com/

---

SYNPOSIS

First, Dr. Ehdaie shares personal experiences from starting pilot trials, engaging stakeholders, and integrating trial processes into clinical practice. He also discusses mechanisms to reduce cost and improve enrollment while explaining the concept of two-stage consent to minimize patient anxiety. This episode aims to provide valuable pearls for young investigators and experienced practitioners alike on conducting successful clinical trials.

---

TIMESTAMPS

00:00 - Introduction

04:39 - Challenges in Clinical Trials

06:21 - Case Study: Focal Therapy Trial

16:45 - Case Study: Hernia Trial

20:17 - Innovation in Clinical Trials

26:25 - Two-Stage Consent

36:11 - Final Thoughts

---

RESOURCES

Photocure

https://www.photocure.com/

---

This podcast is supported by:

Veracyte

https://www.veracyte.com/decipher

---

SYNPOSIS

The doctors focus on the difficulty in declaring a patient 'cured' and the implications of biochemical recurrence after treatment. Dr. Morgan highlights the importance of PSA in the postoperative setting and explores the role of the Decipher Prostate Genomic Classifier in personalizing treatment. He talks through the latest AUA/ASTRO/SUO consensus on biochemical recurrence guidelines, including the significance of early salvage therapy and the integration of advanced imaging techniques like PSMA PET scans. Further, Dr. Morgan emphasizes the role for multidisciplinary evaluation, patient counseling, and future directions of research to refine treatment options.

This discussion underscores the transition from adjuvant to early salvage radiation as a standard practice and considers emerging biomarker strategies to inform treatment decisions.

---

TIMESTAMPS

00:00 - Introduction

03:41 - Consensus Biochemical Recurrence Guidelines

08:56 - Evolution of Post-Prostatectomy Biochemical Recurrence Management

13:24 - Patient Counseling and Risk of Recurrence

17:42 - PSMA PET Scans

20:44 - Postoperative PSA Monitoring

28:35 - The Role of Radiation

31:56 - Hormone Therapy

39:00 - Salvage Lymphadenectomy

46:30 - Future Directions and Concluding Thoughts

---

RESOURCES

Veracyte

https://www.veracyte.com/

Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline (2024)

https://www.auanet.org/guidelines-and-quality/guidelines/salvage-therapy-for-prostate-cancer

---

This podcast is supported by:

Teleflex UroLift

https://www.urolift.com/

---

SYNPOSIS

First, Dr. West delves into the initial patient consultation, diagnostic procedures, and the diverse treatment options for BPH including UroLift, GreenLight laser therapy, and Aquablation. Dr. West emphasizes the importance of individualized patient care, the role of objective symptom scoring systems, and the significance of setting realistic expectations for patients. The discussion also covers the benefits and challenges of different BPH treatments amidst the evolving landscape of minimally invasive urological procedures.

---

TIMESTAMPS

00:00 - Introduction

03:59 - BPH and Voiding Dysfunction

10:21 - Patient-Centered Approach to BPH

19:46 - Diagnostic Workup for BPH

24:53 - Postoperative Catheter and Complications

25:02 - Aquablation

26:04 - UroLift

31:06 - Challenges with Median Lobes

41:02 - Postoperative Care

47:14 - Conclusion

---

SYNPOSIS

The doctors explore the challenges and nuances of patient communication, intravesical therapy, and postoperative surveillance. They also cover emerging treatments and clinical trials that hold promise for improving patient outcomes and quality of life. Emphasis is placed on the distress experienced by patients and the need for personalized treatments.

---

TIMESTAMPS

00:00 - Introduction

01:51 - Initial Consultation

08:01 - TURBT Procedure Insights

23:14 - Managing Low and Intermediate Risk Bladder Cancer

26:47 - Recurrence and Surveillance Strategies

27:48 - Prognostication Tools

30:10 - Intravesical Chemotherapy Options

33:24 - High Grade Tumors

42:33 - Clinical Trials and Emerging Therapies

49:19 - Concluding Thoughts

---

This podcast is supported by:

Veracyte

https://www.veracyte.com/decipher

---

SYNPOSIS

The doctors delve into real-world implementation of active surveillance, alongside the use of advanced diagnostics, biopsy methods, and personalized care plans. The conversation highlights the Canary Prostate Active Surveillance Study (PASS) and the prognostic role of biomarkers and genomic testing. Dr. Lin and Dr. Bagrodia also discuss how lifestyle factors such as diet impact cancer progression and how patients can be empowered to manage their disease. Strategies for transitioning patients off surveillance are highlighted. Finally, the two experts discuss insights from recent clinical trials like PIVOT, PROTECT, and SPCG and how they’re impacting prostate cancer management.

---

TIMESTAMPS

00:00 - Introduction

02:54 - Active Surveillance and Canary PASS Data

12:02 - Biopsy Considerations

19:44 - Active Surveillance Protocols

26:58 - Patient Concerns and Risk Reduction

30:52 - Transitioning Off Surveillance

33:39 - Grade Group 2: Treatment vs. Monitoring

46:24 - Surgical Considerations and Node Dissection

49:25 - Future Directions

---

RESOURCES

Veracyte

https://www.veracyte.com/

---

This podcast was developed in collaboration with:

Society of Urologic Oncology

https://suonet.org/home.aspx

---

SYNPOSIS

The conversation covers critical aspects of RPLND, including surgical techniques, preoperative considerations, common complications like chyle leaks, and post-operative care. Both surgeons emphasize the importance of humility, constant learning, and interprofessional collaboration to enhance surgical outcomes. The experts provide valuable insights and detailed discussions meant to guide urologists.

---

TIMESTAMPS

00:00 - Introduction

01:16 - General Steps for RPLND Surgery

07:23 - Finding the Ureters

11:53 - Vascular Control

23:26 - Mitigating Chyle Leak

32:32 - Conclusion

---

RESOURCES

Expert Approaches to Complex PC RPLND Cases Part 1:

https://www.backtable.com/shows/urology/podcasts/201/expert-approaches-to-complex-pc-rplnd-cases-part-1

Society of Urologic Oncology:

https://suonet.org/home.aspx

---

SYNPOSIS

First, the urologists delve into the technical considerations and perioperative planning for post-chemotherapy retroperitoneal lymph node dissections (RPLND) in patients with germ cell tumors. They discuss the importance of patient preparation, imaging assessments, and surgical approaches. Additionally, they explain their own surgical techniques as well as tips for dealing with operative complications. To end, their discussion addresses the importance of a multidisciplinary team and practical tips for ensuring successful surgical outcomes.

---

TIMESTAMPS

00:00 - Introduction

01:37 - Preparing for Post-Chemotherapy RPLND

08:10 - Intraoperative Considerations

11:02 - Handling Complications

20:11 - Vascular Anatomy and Preoperative Planning

27:13 - Anesthesia Considerations and Pain Management

29:22 - Essential Tools and Techniques for Surgery

38:24 - Incision Strategies and Post-Chemotherapy Considerations

46:32 - Extraperitoneal Approach and Future Research

---

RESOURCES

Society of Urologic Oncologists

https://suonet.org/home.aspx

---

This podcast is supported by:

Veracyte

https://www.veracyte.com/decipher

---

SYNPOSIS

First, they evaluate alternatives to androgen deprivation therapy (ADT), the benefits and risks associated with ADT, and the role of genetic classifier tests. They also detail the goals of prostate-specific antigen (PSA) monitoring, PSA trends post-radiation, and advancements in PSMA PET scans. Then, the conversation highlights modern treatment options like targeted radiation, low dose rate brachytherapy, salvage radical prostatectomy, and focal therapy. Finally, the doctors emphasize personalized and multidisciplinary treatment plans as they hope to improve long-term outcomes for patients with prostate cancer.

---

TIMESTAMPS

00:00 - Introduction

04:31 - PSA Levels Post-Radiation

13:21 - Local Recurrence and PSMA PET

21:29 - Explaining Radiation Effects to Patients

22:41 - Managing PSA Bounce

26:05 - Imaging and Biopsy Techniques

28:55 - Treatment Options for Local Recurrence

30:16 - Re-Irradiation and Focal Therapy

33:13 - Concluding Thoughts

---

RESOURCES

Veracyte

https://www.veracyte.com/

---

This podcast is supported by:

Photocure

https://www.photocure.com/

---

SYNPOSIS

This episode emphasizes the importance of awareness and peer support in reducing isolation and stigma associated with penile cancer. The conversation also explores the role of multidisciplinary care and the benefits of holistic approaches to patient decision-making.

---

TIMESTAMPS

00:00 - Introduction

04:05 - Isolation in Penile Cancer

06:38 - The Role of Advocacy and Peer Support

15:29 - Shared Decision Making in Penile Cancer Care

23:22 - Value of Multidisciplinary Care

---

RESOURCES

Photocure

https://www.photocure.com/

Global Society of Rare GU Tumors (GSRGT)

https://www.gsrgt.com

---

This podcast is supported by:

Photocure

https://www.photocure.com/

---

SYNPOSIS

Los doctores exploran las complejidades de navegar la atención urológica, la importancia de cumplir con el estándar de atención a pesar de las limitaciones sistémicas y el panorama en evolución de la urología reconstructiva y protésica. El Dr. Soto comparte anécdotas personales, el impacto de la pandemia de COVID-19 en su práctica y el papel crucial de la colaboración comunitaria y profesional en el avance de los servicios urológicos en Puerto Rico. El episodio destaca la dedicación necesaria para mejorar la calidad de vida del paciente y adaptarse a las nuevas tecnologías médicas.

---

TIMESTAMPS

00:00 - Viaje a la Urología Reconstructiva

08:32 - Decisión de Quedarse en Detroit

13:31 - Regresando al Puerto Rico

27:47 - Tratamientos Urológicos en América Latina

30:18 - Equilibrio entre la Práctica Privada y las Necesidades de la Comunidad

36:32 - Prácticas y Técnicas Quirúrgicas

41:25 - La Importancia del Aprendizaje Continuo

52:45 - Pensamientos Finales

---

RESOURCES

Photocure

https://www.photocure.com/

---

This podcast is supported by:

Photocure

https://www.photocure.com/

---

SYNPOSIS

Their conversation offers interesting historical detail on the evolution of kidney stone treatment, from open surgery to modern techniques including percutaneous nephrolithotomy, shockwave lithotripsy, and ureteroscopy. As one of the original visionaries behind CVAC, Dr. Sur highlights the development journey from lab experiments to FDA approval. The episode covers data on CVAC’s superiority in patient outcomes and stone-free rates compared to other technologies. Key insights from recent studies, such as the ASPIRE trial, underscore the benefits of CVAC in reducing postoperative events and stone regrowth. The conversation also explores practical aspects of integrating suction platforms into practices and looks ahead towards the potential for machine learning to refine these technologies.

---

TIMESTAMPS

00:00 - Introduction

04:29 - The Rise of Ureteroscopy

10:38 - Development of Suction Devices

12:22 - The CVAC Device: History and Functionality

21:05 - Comparing Suction Device Systems

31:34 - Looking Into the Data

37:42 - Considerations for Real-World Practice

---

RESOURCES

Photocure

https://www.photocure.com/

---

SYNPOSIS

The doctors systematically cover the process of identifying market needs, inventing solutions, bringing a product to the market, and managing risk. They also share examples of successful startup ventures and underscore the importance of perseverance, innovative thinking, and strategic market focus in forging a path to success.

---

TIMESTAMPS

00:00 - Introduction

04:30 - The Birth of a Surgical Trainer

07:04 - Challenges and Innovations in Trauma Surgery

22:06 - Evaluating and Killing Ideas

28:27 - Challenging Assumptions

29:53 - Meeting a Co-Founder

33:07 - Developing the Solution

37:29 - Raising Funds

40:28 - Navigating Regulatory Challenges and Market Expansion

---

RESOURCES

Watershed Therapeutics:

https://www.watershedtx.com/

Stanford Biodesign Innovation Fellowship:

https://biodesign.stanford.edu/programs/fellowships/innovation-fellowships.html

---

SYNPOSIS

The episode covers tips for both virtual and in-person interviews, strategies for conversational engagement, and advice for how applicants should evaluate programs. They further detail aligning personal values with program culture, describing past challenges, and lowering interview anxiety through effective practice. The conversation offers applicants invaluable preparation tips to approach the interview process with confidence and a positive attitude.

---

TIMESTAMPS

00:00 - Introduction

02:32 - Virtual vs. In-Person Interviews

07:02 - Preparing for Residency Interviews: Tips and Strategies

17:29 - The Role of Research

20:43 - Pivoting to Leadership and Advocacy

22:01 - Behavioral Questions: Tips and Examples

26:22 - Discussing Difficult Subjects

28:26 - Choosing the Right Residency Program

33:10 - Post-Interview Communication

36:24 - Final Advice

---

This podcast is supported by:

Boston Scientific Urology

https://www.bostonscientific.com/en-US/about-us/core-businesses/urology-pelvic-health.html

---

SYNPOSIS

Dr. Riley discusses the benefits of access sheaths, the utility of new devices including LithoVue Elite, and strategies for minimizing infection. She highlights the benefits and intended use cases of this new technology, and further outlines potential complications and challenges in using this new tool. Dr. Riley also shares her own approaches to complex patients, and her predictions for the future of ureteroscopy.

---

TIMESTAMPS

00:00 - Introduction

03:10 - Ureteroscopy and Patient Candidacy

04:12 - Complications

09:50 - Technological Advances

13:30 - Practical Tips

32:59 - Looking Ahead

---

RESOURCES

Boston Scientific

https://www.bostonscientific.com/en-US/home.html

---

SYNPOSIS

They review pivotal trials like the NIAGARA and AMBASSADOR studies, the TAR-200 drug delivery system, the use of bladder-sparing treatment, and the role of ctDNA as a biomarker. Further, they detail the effectiveness of systemic therapies such as gemcitabine and pembrolizumab, the implications of perioperative immunotherapy, and the future role of antibody-drug conjugates. The conversation highlights the trend towards less invasive approaches while improving survival rates from bladder cancer.

---

TIMESTAMPS

00:00 - Introduction

03:49 - NIAGARA Trial

09:10 - Challenges in Bladder Cancer Treatment

18:56 - AMBASSADOR Trial

25:30 - Adjuvant Immunotherapy

29:30 - Exploring Biomarkers and ctDNA

36:34 - Surgery and Less Invasive Therapies

46:31 - Future Directions in Bladder Cancer Treatment

---

RESOURCES

ESMO

https://www.esmo.org/

---

This podcast is supported by:

Photocure

https://www.photocure.com/

---

SYNPOSIS

Dr. Santiago, a Latina from Puerto Rico and a first-generation physician, highlights the latest data on pay, research funding, and professional advancement for women physicians. They debunk common myths, discuss the importance of transparency, and emphasize the need for inclusive work environments. The conversation also covers the economic phenomena underlying current discrepancies and the benefits of fostering diversity. This episode offers valuable insights for leaders on retaining and nurturing talent within their organizations.

---

TIMESTAMPS

00:00 - Introduction

06:28 - Impact of Menopause and Women’s Health

10:33 - Gender Gaps in Urology

31:52 - The Meritocracy Myth

35:56 - The Abrasiveness Trap and Gender Schema

40:04 - Navigating Work Personalities

47:54 - Leadership and Inclusivity in Organizations

51:30 - Tokenism vs. True Inclusion

56:58 - The Benefits of a Diverse Workforce

---

RESOURCES

Photocure

https://www.photocure.com/

---

This podcast is supported by:

Boston Scientific SpaceOAR Hydrogel

https://www.spaceoar.com/about-spaceoar-hydrogel/how-spaceoar-hydrogel-works/?utm_source=google&utm_medium=cpc&utm_campaign=uro-ph-us-spaceoar-dtp&utm_content=nf-cs-prostatecancer_search_en_us_brand_conversion_dtp_uro-spaceoar-651995397243-res&gad_source=1&gclid=CjwKCAjw9eO3BhBNEiwAoc0-jTE63KEHSnZ1soXre9ovVRqweY2QctIuZ_iN2QUjk6Px4k6fK1757BoCVNgQAvD_BwE

---

SYNPOSIS

Their conversation delves into the use of Boston Scientific’s SpaceOAR hydrogel to reduce radiation exposure to the rectum. The experts elaborate on the techniques and logistical challenges of placing spacers, as well as their effects on patient outcomes. They also discuss insurance hurdles, use of sedation, fiducial marker placement, and the impact of large prostate size on treatment efficacy. Finally, they touch on Barrigel, the newest spacer option. This episode emphasizes the need for collaboration between urologists and radiation oncologists to improve patient care.

---

TIMESTAMPS

00:00 - Introduction

06:33 - Importance of Perirectal Spacing

11:17 - Techniques and Protocols

13:00 - Barrigel: The New Option

14:58 - Challenges and Practical Considerations

24:55 - Future Directions

---

RESOURCES

Boston Scientific SpaceOAR

https://www.bostonscientific.com/en-US/products/hydrogel-spacers/spaceoar-hydrogel.html

URO108 - Minimizing Radiation Therapy Side Effects

https://www.backtable.com/shows/urology/podcasts/108/minimizing-radiation-therapy-side-effects

URO123 - Perfecting Rectal Spacer Placement for Optimal Care

https://www.backtable.com/shows/urology/podcasts/123/perfecting-rectal-spacer-placement-for-optimal-care

---

CHECK OUT OUR SPONSOR

Boston Scientific Rezum Water Vapor Therapy

https://www.bostonscientific.com/rezum

---

SYNPOSIS

Hollander and Shah discuss the importance of effective APP training and onboarding. Dr. Shah shares his wisdom on structuring an APP program to ensure that new practitioners are educated, compliant, and satisfied; all while helping to address the current urologist shortage. The discussion also covers BPH workflows, effective follow-up, and staying up to date on evolving medical knowledge in the context of innovations such as GreenLight Laser and UroCuff.

---

TIMESTAMPS

00:00 - Introduction

06:58 - Nicole’s APP Journey

07:42 - Training APPs

12:22 - BPH Workflow

21:04 - Deciding on Procedures for BPH

26:40 - Rezum

33:40 - Ensuring APP Clinical Excellence and Compliance

36:34 - APP Career Development and Retention

40:31 - Looking Ahead

---

CHECK OUT OUR SPONSORS

Siemens Healthineers Theranostics

https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics

Photocure

https://www.photocure.com/

---

SYNPOSIS

Dr. Menon reflects on how robotic prostatectomy techniques have evolved over his career. He shares his journey from India to the United States, highlighting his trailblazing work at the Vattikuti Urology Institute at Henry Ford Hospital. He also talks about the challenges of working with robotic technology, recent advancements in the field, and what the future may hold for robotic surgery.

---

TIMESTAMPS

00:00 - Introduction

03:05 - Dr. Menon’s Early Life

06:51 - Experiences of an International Medical Graduate

19:51 - The Move to Henry Ford

36:44 - Transitioning to Robotic Surgery

41:36 - Patient Outcomes and Reflections

47:50 - Technological Advancements in Surgery

55:52 - Looking Ahead

---

RESOURCES

Photocure

https://www.photocure.com/

Siemens Healthineers

https://www.siemens-healthineers.com/en-us/urology-equipment

---

CHECK OUT OUR SPONSOR

KYZATREX™

https://www.kyzatrex.com

---

SYNPOSIS

Dr. Morgenhaler starts by sharing his pioneering journey with testosterone replacement therapy starting in the 1980s, challenging long-held beliefs that it increases prostate cancer risk. He highlights key studies to debunk myths about testosterone’s dangers and emphasizes the ability to improve patients’ quality of life. Further, he discusses modern treatment options and provides practical advice for safely initiating testosterone replacement therapy. Finally, he discusses its use in patients with a history of prostate cancer and emphasizes the importance of individualized treatment plans.

---

TIMESTAMPS

00:00 - Introduction

03:04 - Historical Perspectives on Testosterone and Prostate Cancer

21:31 - Evolution of Testosterone Treatments

31:16 - Testosterone and Prostate Cancer: A Controversial History

35:42 - Treating Prostate Cancer Patients with Testosterone

37:12 - A Case Study

43:05 - Shifting Perspectives

57:15 - Final Thoughts

---

RESOURCES

T4L Education

https://t4leducation.com/

Marius Pharmaceuticals

https://mariuspharma.com/

Testosterone Replacement in Prostate Cancer Survivors URO98

https://www.backtable.com/shows/urology/podcasts/98/testosterone-replacement-in-prostate-cancer-survivors

Men's Health & Testosterone Replacement Therapy URO114

https://www.backtable.com/shows/urology/podcasts/114/mens-health-testosterone-replacement-therapy

Testosterone & Hypogonadism: A Clinical Perspective URO124

https://www.backtable.com/shows/urology/podcasts/124/testosterone-hypogonadism-a-clinical-perspective

Testosterone: Navigating Options & Implementation in Clinical Practice URO 125

https://www.backtable.com/shows/urology/podcasts/125/testosterone-navigating-options-implementation-in-clinical-practice

---

CHECK OUT OUR SPONSOR

PearsonRavitz

https://pearsonravitz.com/backtable

---

SYNPOSIS

The conversation covers noteworthy statistics on burnout, accessibility to mental health care, and practice patterns within the urologic community. The doctors also discuss the evolution in demographics amongst practicing urologists, improvement in diversity, equity, and inclusion initiatives, and the growing concern of workforce shortages. Finally, the episode explores the importance of this census data in informing AUA advocacy efforts to shape future government policies.

---

TIMESTAMPS

00:00 - Introduction

06:04 - The AUA Census

11:20 - Demographics of Urologists in the U.S.

22:48 - Trends in Private Practice and Employment

38:00 - Burden of Prior Authorizations

43:17 - Addressing Burnout

45:29 - Diversity, Equity, and Inclusion

52:43 - Conclusion

---

RESOURCES

Pearson Ravitz

https://pearsonravitz.com/

Photocure

https://www.photocure.com/

---

CHECK OUT OUR SPONSOR

Photocure

https://www.photocure.com/

---

SYNPOSIS

The doctors start by discussing the advantages of using blue light cystoscopy, including better detection rates of Ta and T1 lesions and the reduction of cancer recurrence by as much as 11%. They highlight the importance of complete transurethral resection of bladder tumor (TURBT) and patient compliance. Dr. Merrill emphasizes the necessity of accurate risk stratification and the logistics of real-life incorporation. Finally, she also comments on new bladder cancer technologies, such as narrow band imaging.

---

TIMESTAMPS

00:00 - Introduction

03:45 - Epidemiology and Risk of Bladder Cancer

05:48 - AUA Guidelines for Bladder Cancer

08:01 - Mechanism and Benefits of Blue Light Cystoscopy

10:33 - Practical Applications

34:48 - Conclusion

---

RESOURCES

Photocure

https://www.photocure.com/

---

SYNPOSIS

Dr. Boone reflects on his personal journey into urology and his experiences in education and administration. The urologists emphasize the significance and joys of patient relationships and effective mentorship for other doctors. Furthermore, they offer advice for young urologists on self-reflection, time management, and the art of doctoring.

---

TIMESTAMPS

00:00 - Introduction

05:00 - Early Influences and Career Path

24:28 - Challenges in Maintaining Empathy

29:19 - The Importance of Self-Reflection

33:24 - Recruitment and Retention in Leadership

36:12 - Balancing Personal Life

42:03 - Innovative Medical Education

48:54 - Final Thoughts

---

RESOURCES

Pearson Ravitz

https://pearsonravitz.com/

BackTable URO24 - Operate with Zen

https://www.backtable.com/shows/urology/podcasts/24/operate-with-zen

---

SYNPOSIS

The “second victim phenomenon” refers to the negative emotional response a healthcare worker endures after a traumatic patient care event. The conversation explores the psychological impacts of surgical complications as Dr. Peters describes the phases of coping. She emphasizes the need to distinguish between personal failure and professional setbacks and highlights the importance of peer and institutional support. The discussion also delves into recent cultural shifts in medicine, especially in the wake of COVID-19. The experts conclude by discussing steps for progress and improvement within the surgical work environment.

---

TIMESTAMPS

00:00 - Introduction

02:00 - Second Victim Phenomenon

06:52 - Challenges for Trainees

09:43 - Managing Complications

17:04 - Phases of Emotions

20:31 - Peer Support and Institutional Resources

35:04 - Building a Supportive Training Environment

---

RESOURCES

Pearson Ravitz

https://pearsonravitz.com/

BackTable URO24- Operate with Zen

https://www.backtable.com/shows/urology/podcasts/24/operate-with-zen

BackTable URO39- The Anatomy of a Complication https://www.backtable.com/shows/urology/podcasts/39/the-anatomy-of-a-complication-surgeon-health

BackTable URO42- Mental Constructs to Avoid Complications https://www.backtable.com/shows/urology/podcasts/42/mental-constructs-to-avoid-complications

---

CHECK OUT OUR SPONSOR

PearsonRavitz

https://pearsonravitz.com/backtable

---

SYNPOSIS

First, Dr. Boyles explains the importance of patient history and physical examination, along with the need for certain diagnostic tests for proper characterization of the type of urinary incontinence in a patient. She also explores behavioral treatments, pelvic floor physical therapy, vaginal pessaries, and advanced interventions such as urethral bulking and surgery for stress incontinence. The doctors further discuss innovative pharmaceutical and neuromodulation options for urge incontinence.

Dr. Boyles concludes with a mention of patient education resources that are available on her platform, thewomensbladderdoctor.com.

---

TIMESTAMPS

00:00 - Introduction

02:35 - The Women’s Bladder Doctor Initiative

07:03 - Types of Urinary Incontinence

11:49 - Diagnostic Approaches to Urinary Incontinence

28:39 - Treatment Algorithms for Urinary Incontinence

31:12 - Bladder Retraining and Pelvic Floor Therapy

40:00 - Urethral Seals and Vaginal Pessaries

50:47 - Treatment for Urgency

57:51 - Future Directions

---

RESOURCES

Pearson Ravitz

https://pearsonravitz.com/

The Women’s Bladder Doctor

https://thewomensbladderdoctor.com/

---

CHECK OUT OUR SPONSOR

Fellow

https://www.meetfellow.com/

---

SYNPOSIS

The conversation covers the importance of introspection, geography, and mentorship. Dr. Shkoliar also delves into practical aspects of networking, job offer negotiation, and the balance between professional aspirations and personal life. Dr. Shkoliar shares personal experiences from this career milestone.

---

TIMESTAMPS

00:00 - Introduction

02:17 - The Job Search

09:13 - Balancing Personal and Professional Goals

16:43 - Exploring Different Career Paths

22:26 - Understanding Healthcare Structures

26:14 - Practical Steps

30:07 - Mentorship and Networking

37:39 - Negotiation Tactics

49:48 - Final Reflections

---

RESOURCES

Fellow

https://www.meetfellow.com/

---

SYNPOSIS

Dr. Moran shares his approach to studying medical guidelines, using the spaced repetition app, Anki, and preparing for the annual in-service exam. The doctors also discuss GAMERS, a surgical simulation competition started by Dr. Moran intended to improve robotic skills. Finally, Dr. Moran speaks to the importance of adaptability, personalization, and mentorship in effective learning during residency.

---

TIMESTAMPS

00:00 - Introduction

02:38 - Strategies for Learning Medical Knowledge

09:08 - Preparing for Exams

16:14 - Robotic Simulation

21:46 - Final Wisdom

---

CHECK OUT OUR SPONSOR

Siemens Healthineers Theranostics

https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics

---

SYNPOSIS

The conversation initially focuses on advanced urothelial carcinoma and the EV302 trial, discussing detailed insights from the quality-of-life results presented at ASCO. The experts offer relevant clinical perspectives for modern metastatic urothelial carcinoma management, focusing on pembrolizumab plus enfortumab vedotin. Further, they delve into breaking biomarker research at ASCO, including KIM-1 in adjuvant renal cell carcinoma (RCC) therapy and the HIF-2 inhibitor DFF332 for chromophobe RCC.

---

TIMESTAMPS

00:00 - Introduction

03:42 - Pembrolizumab and Enfortumab Vedotin Trial Insights

07:43 - Future Trials and Treatment Strategies

21:27 - Javelin Bladder 100 Trial Discussion

32:05 - Growth Factor Use

36:21 - Future Directions of Biomarkers

38:55 - Kidney Cancer Biomarker Trials

53:40 - Concluding Thoughts

---

CHECK OUT OUR SPONSOR

Siemens Healthineers Theranostics

https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics

---

SYNPOSIS

Dr. Kamat explores the evolving role of BCG and potential alternative therapies such as gemcitabine and docetaxel. He also covers effective clinical management, emerging clinical trials, and nuanced decision-making principles for radical cystectomy. Finally, the conversation touches on Dr. Kamat’s expert insights regarding the future of NMIBC management, including predictive biomarkers and personalized medicine.

---

TIMESTAMPS

00:00 - Introduction

03:56 - Initial Diagnosis and Workup

12:22 - High-Grade Bladder Cancer

22:37 - BCG and Alternative Treatments

31:30 - BCG Unresponsive Disease

36:56 - Novel Intravesical and Systemic Therapies

46:45 - Future Directions

---

RESOURCES

Related BackTable episodes:

https://www.backtable.com/shows/urology/podcasts/64/management-of-bcg-refractory-nmibc

https://www.backtable.com/shows/urology/podcasts/157/the-bladder-cancer-matters-podcast

https://www.backtable.com/shows/urology/podcasts/103/adjuvant-therapy-for-high-risk-bladder-cancer

---

CHECK OUT OUR SPONSOR

Fellow

https://www.meetfellow.com/

---

SYNPOSIS

First, the two experts discuss personal experiences in family planning and challenges faced regularly in the hospital environment. They outline the complexities of assisted reproductive technology and offer insights for a better path forward, including cultural shifts, new policies, and supportive resources to better accommodate the needs of female surgeons.

---

TIMESTAMPS

00:00 - Introduction

04:05 - Dr. Holdren and Dr. Van Horn’s Journeys

06:57 - Challenges in Family Planning

17:51 - Parental Leave Policies

26:56 - Advanced Reproductive Technology

33:46 - Looking Towards the Future

---

RESOURCES

Fellow

https://www.meetfellow.com/

---

SYNPOSIS

Dr. Ibeziako offers practical advice on managing competing responsibilities, building relationships with hospital staff, and developing early surgical skills. She offers valuable personal insights on self-directed study, triage of tasks, and making the most of these valuable years to set up for a successful career ahead.

---

TIMESTAMPS

00:00 - Introduction

05:43 - Early Residency Challenges

10:51 - Relationships with Nursing

14:23 - Multitasking

24:06 - Developing Surgical Skills as an Intern

33:09 - Continuous Learning and Final Pearls of Wisdom

---

CHECK OUT OUR SPONSOR

Siemens Healthineers Theranostics

https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics

---

SYNPOSIS

Dr. Hiller emphasizes the importance of patient education, bladder retraining, and the holistic management of incontinence. The conversation also touches on the science of lasers, effective morcellation, and practical challenges in achieving successful outcomes.

---

TIMESTAMPS

00:00 - Introduction

07:58 - HoLEP Patient Counseling

21:29 - HoLEP Surgical Techniques

33:54 - Morcellation: Challenges and Best Practices

37:16 - Post-Operative Care

47:21 - Postoperative Urinary Symptoms

---

SYNPOSIS

Their conversation covers the capabilities and benefits of using an AI-driven medical scribe that ensures HIPAA compliance, reduces physician burnout, and enhances patient interactions. Elie also shares his insights about the technology’s adaptability across various medical fields. Finally, Dr. Bagrodia and Elie discuss ethical considerations surrounding applications of AI in other aspects of healthcare, such as medical workup and diagnosis.

---

TIMESTAMPS

00:00 - Introduction

06:00 - How ScribeMD AI Works

14:14 - Integration with EMR

20:31 - Legal Considerations with AI Technology

26:34 - Cost Implications of AI Scribes

38:46 - Future of AI in Medical Diagnosis

41:45 - Conclusion and Final Thoughts

---

RESOURCES

ScribeMD.ai

https://www.scribemd.ai/

---

CHECK OUT OUR SPONSOR

Veracyte

https://www.veracyte.com/decipher

---

SYNPOSIS

First, the doctors cover noteworthy topics, including the effectiveness of early screening and treatment for high-risk prostate cancer patients, innovative approaches in imaging and biomarkers, and the impact of new guidelines on salvage therapy. They also explore emerging treatments for non-muscle invasive bladder cancer (NMIBC), as well as the evolving role of systemic immunotherapies and advanced genomic testing. To wrap up, the urologists offer detailed analyses and their expert opinions on how these developments could transform patient care in the field of urologic oncology.

---

TIMESTAMPS

00:00 - Introductions

03:06 - Prostate Cancer Screening Insights

10:10 - Advancements in MRI and Biomarkers

18:22 - Transperineal vs. Transrectal Prostate Biopsy

27:18 - New Guidelines for Bladder Cancer Treatment

30:57 - Innovative Drug Delivery Systems

32:36 - Gene Therapy and Immunotherapy Advances

40:11 - Concluding Thoughts and Future Prospects

---

RESOURCES

Decipher Prostate Genomic Classifier by Veracyte:

​​https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/

---

CHECK OUT OUR SPONSOR

Fellow

https://www.meetfellow.com/

---

SYNPOSIS

The doctors delve into the increasing costs of healthcare, the challenges posed by regulatory requirements, and the significance of physician leadership in influencing healthcare delivery. The discussion also highlights the importance of advocacy, the evolving role of physicians in business and policy, and actionable steps doctors can take to ensure their voices are heard. Finally, the doctors address the growing trend of hospital employment among physicians and its impact on rural healthcare access.

---

TIMESTAMPS

00:00 - Introduction

06:41 - Complexities and Costs in Healthcare

11:48 - The Role of Physicians in Healthcare Leadership

17:21 - The Shift Towards Hospital Employment

27:35 - Economic Pressures on Physicians and Patients

30:09 - Cost Discrepancies in Medical Procedures

38:16 - Burnout and Workforce Challenges

49:26 - Advocacy and Call to Action

---

RESOURCES

Fellow

https://www.meetfellow.com/

BackTable URO Ep. 82- Advocacy Basics for the Urologist: From Your Clinic to Capitol Hill with Dr. Ruchika Talwar

https://open.spotify.com/episode/0hcLrKuf5QU7TZCHSErs4Z?si=842c7985f44c4e04

BackTable URO Ep. 164: Urology Advocacy: From Passion to Policy with Dr. Seth Cohen, Dr. Michelle Leach, and Dr. Suzette Sutherland

https://open.spotify.com/episode/68pR7MxFIgQ1HJLy6xQHDX?si=36a93eedd6594770

---

CHECK OUT OUR SPONSORS

Siemens Healthineers Theranostics

https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics

Veracyte

https://www.veracyte.com/decipher

---

SYNPOSIS

First, the doctors discuss the society’s mission to improve the diagnosis and treatment of rare genitourinary cancers globally. They give an overview of their educational efforts, international collaborations, and significant achievements in clinical research. The discussion also covers the importance of global representation, the challenges of studying rare tumors, and future directions, such as leveraging artificial intelligence. The episode concludes with an emphasis on the society’s commitment to being inclusive and providing opportunities for young investigators.

---

TIMESTAMPS

00:00 - Introduction

06:45 - Origins and Missions of GSRGT

11:21 - Challenges in Rare Cancer Research

31:51 - Future Directions in Rare Cancer Treatment

38:38 - How to Get Involved with GSRGT

---

RESOURCES

Siemens Healthineers Theranostics:

https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics

Decipher Prostate Genomic Classifier by Veracyte:

​​https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/

GSRGT Website

https://www.gsrgt.com/

Andrea Necchi Website

https://www.andreanecchi.com/

---

CHECK OUT OUR SPONSORS

Siemens Healthineers Theranostics

https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics

Veracyte

https://www.veracyte.com/decipher

---

SYNPOSIS

First, the doctors discuss focal therapy in prostate cancer treatment from various perspectives, including the challenges of treating certain lesions, the comparison of different focal therapy modalities like high-intensity focused ultrasound (HIFU) and brachytherapy, cryotherapy and the importance of patient-specific factors in treatment decisions. They emphasize the need for clinical trials and registries to validate focal therapy outcomes, the potential expansion of indications for focal therapy, and the critical role of advanced imaging and genomic classifiers in patient selection and treatment planning. The discussion also touches on the potential of focal therapy to evolve as a standard care option alongside advancements in understanding the biology of prostate cancer and improving imaging and treatment technologies.

---

TIMESTAMPS

Siemens Healthineers Theranostics:

https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics

Decipher Prostate Genomic Classifier by Veracyte:

​​https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/

---

RESOURCES

Siemens Healthineers Theranostics:

https://www.siemens-healthineers.com/en-us/clinical-specialities/theranostics

Decipher Prostate Genomic Classifier by Veracyte:

​​https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/

---

CHECK OUT OUR SPONSOR

KYZATREX™

https://www.kyzatrex.com

---

SYNPOSIS

First, Ken highlights his journey into men’s health, sparked by the debut of erectile dysfunction medication and his engagement in vascular medicine. He then discusses how he leveraged his clinical background to address prevalent issues such as erectile dysfunction and testosterone management. Ken emphasizes the importance of education, collaboration, and innovative treatment approaches in providing effective patient care. Dr. Silva and Ken also cover the potential of oral testosterone treatments and their growing acceptance among patients due to convenience and cost-effectiveness. Ken shares insights into his role in advancing APP utilization in urology practices and ensuring comprehensive care coverage. Finally, Ken introduces his nonprofit organization, GUYnecology Men’s Health, an initiative aimed at fostering a broader understanding of preventative care among patients and healthcare professionals.

---

TIMESTAMPS

00:00 - Introduction

06:28 - Expanding the Role of APPs in Urology

14:47 - Addressing Testosterone Replacement Therapy

21:40 - Exploring Treatment and Insurance Challenges in Urology Practices

27:35 - The Evolution of Oral Testosterone Treatments

35:29 - Incorporating Telehealth and Enhancing Patient Education

36:03 - Introducing Guynecology: A New Approach to Men’s Health

41:44 - Final Thoughts and Advice for Urologists and APPs

---

RESOURCES

KYZATREX

https://www.kyzatrex.com/

GUYnecology Men’s Health Association

https://learnguynecology.org/

---

CHECK OUT OUR SPONSOR

Fellow

https://www.meetfellow.com/

---

SYNPOSIS

First, Dr. Smith introduces the significance of a comprehensive approach to examining male fertility, including total motile sperm counts and treatable conditions like prostatitis. He also highlights the role of the Fellow kit, a mail-in semen analysis test that improves the access and availability of sperm analysis. He explains the scientific foundations behind the Fellow kit, including temperature control, nutrient supply, and antibacterial measures to preserve sperm motility. The episode also touches on broader themes in fertility, such as the impact of illnesses like COVID-19 on sperm quality, the potential for future molecular and genetic testing in semen analysis, and the socioeconomic factors affecting access to fertility testing. Finally, Dr. Smith emphasizes the importance of early and comprehensive fertility evaluations for men and discusses the potential for future research to further improve fertility diagnostics.

---

TIMESTAMPS

0:00 - Exploring Fertility Challenges and Solutions

10:16 - The Game-Changing Impact of the Fellow Semen Analysis Kit

15:29 - Navigating Semen Analysis: Quality, Progression, and Treatment

22:51 - The Importance of Early Fertility Testing and Intervention

27:27 - The Journey of Fellow: Improving Patient Compliance and Access

41:08 - The Future of Semen Analysis and Fertility Research

44:25 - Concluding Thoughts on Male Fertility and Patient Care

---

RESOURCES

Fellow Website

https://www.meetfellow.com/

---

SYNPOSIS

Dr. Tova Weiss, a urology resident at the University of Washington, discusses her development of a safer urinary catheter so that if a patient were to pull out their catheter, the distal part would disconnect from the catheter inside the urethra, preventing urethral trauma. Dr. Jay Shakuri-Rad, a practicing urologist specializing in robotics and neuromodulation, shares his creation of the Foramen Finder to enhance sacral neuromodulation procedures. Dr. Allie Haessler, a practicing urogynecologist, talks about her invention of a novel vaginal ring aimed at providing neuromodulation therapy for pelvic floor issues. They each discuss the inspiration behind their inventions, challenges faced, and the importance of failure in the path to innovation. The episode emphasizes the role of physicians in identifying healthcare gaps, collaborating across disciplines, and pushing the boundaries of medical technology to improve patient care.

---

TIMESTAMPS

00:00 - Introduction

01:54 - Dr. Tova Weiss and the Urinary Catheter Accessory

08:49 - Dr. Jay Shakuri-Rad and the Foramen Finder

22:04 - Dr. Allie Haessler and the Neuromodulation Vaginal Ring

27:29 - Navigating the Patent Process and Protecting Innovation

29:52 - The Path to FDA Approval

37:11 - Advice for Aspiring Innovators in Medicine

40:52 - Embracing Failure and the Inventor’s Mindset

---

SYNPOSIS

First, Dr. Harris shares his transformative journey into quality improvement following a personal experience in the operating room, highlighting how critical it is for healthcare professionals to scrutinize and refine daily processes for better outcomes. The conversation dives into the heart of quality improvement, complex problem solving, encouraging healthcare professionals to apply their analytical skills to improve systems and processes. They discuss the importance of communication, team involvement, and leadership in fostering a culture that embraces quality improvement. Practical examples from Harris’s experience underscore how small changes can lead to significant benefits in patient care, staff satisfaction, and overall healthcare efficiency.

---

TIMESTAMPS

00:00 - Introduction

05:16 - Combating Burnout with Quality Improvement Initiatives

13:38 - Exploring the Anatomy of a Quality Improvement Project

25:24 - Optimizing Operating Room Efficiency

28:37 - Balancing Standardization and Flexibility in Healthcare Processes

34:11 - Ad Hoc Solutions vs. Structured Quality Improvement

40:36 - Incorporating Patient Perspectives in Quality Improvement

Dr. Cohen and Dr. Leach first discuss their personal journeys into advocacy work, the projects they’ve been involved in, and the tangible changes they have helped make, including a resident book club and increasing access to sacral neuromodulation. They both emphasize the importance of physician involvement in advocacy at both the beginning and throughout their careers. They also provide practical advice on participating in professional organizations (AUA, AMA, etc.) and the importance of surveys in guiding advocacy efforts. The discussion concludes with encouragement for medical professionals to engage in policy and advocacy to safeguard their practice and enhance patient care.

---

SHOW NOTES

00:00 - Introduction

16:50 - Real-World Success Stories

25:36 - Navigating the Complexities of Health Policy and Advocacy

33:06 - The Importance of Membership in Professional Organizations

36:14 - Highlighting Urology’s Influence in Health Policy

45:14 - The AUA Summit Experience

55:23 - The Value of Engagement and Advocacy

---

RESOURCES

Ep. 82- Advocacy Basics for the Urologist: From Your Clinic to Capitol Hill with Dr. Ruchika Talwar

https://www.backtable.com/shows/urology/podcasts/82/advocacy-basics-for-the-urologist-from-your-clinic-to-capitol-hill

Ep. 154- Navigating Healthcare Reform: Lessons from Urology Advocacy with Dr. Mara Holton

https://www.backtable.com/shows/urology/podcasts/154/navigating-healthcare-reform-lessons-from-urology-advocacy

First, they delve into the Stark Law restrictions on physician referrals and the unique legal status of lithotripsy services. The conversation also covers partnership benefits, compliance strategies for different services, the importance of due diligence, and considerations for physicians looking to invest in or maintain ancillary income through such partnerships. Additionally, they explore the impact of the Federal Sunshine Act on partnership reporting obligations, as well as advice for navigating hospital policies and ensuring legal and financial protections when engaging in these partnerships.

---

SHOW NOTES

00:00 - Introduction

06:38 - Exploring Physician Partnerships and Investment Models

10:28 - Navigating Legal and Regulatory Aspects of Urology Partnerships

12:43 - Investment Strategies and Compliance for Urologists

21:42 - Addressing Common Concerns and Opportunities in Urology Partnerships

34:53 - Advice on Urology Partnerships

---

RESOURCES

HealthTronics

https://www.healthtronics.com/

First, Dr. Bowman shares his journey towards leadership, starting from his junior residency years and leading up to his current chief resident role and soon-to-be faculty position at UCSF. Max discusses the importance of setting clear expectations, direct communication, and maintaining friendships despite hierarchical differences in residency. The conversation also highlights the benefits of proactive mentorship, the persistent pursuit of leadership opportunities, and the value of leading by example. The urologists then summarize intentional leadership development in medical training and offer advice for residents and early career faculty aiming to enhance their leadership skills.

---

SHOW NOTES

00:00 - Introduction

07:37 - Intentional Leadership Development

17:51 - Balancing Friendship and Authority

20:42 - Crafting a Culture of Leadership

32:44 - Seeking and Embracing Leadership Opportunities

---

RESOURCES

Episode 145 - Urology Training: From Intern to Expert with Dr. Gina Badalato and Dr. Lindsay Hampson

https://www.backtable.com/shows/urology/podcasts/145/urology-training-from-intern-to-expert

First, they delve into the “Terrible Urological Five”, a set of criteria indicating when it might be necessary to consider cystectomy and urinary diversion. Dr. Peterson shares his insights on patient care, emphasizing how long-term follow-up and comprehensive care can transform survivors’ quality of life. He also addresses the psychological aspects of major urological surgery, highlighting the importance of acceptance and adjustment for patients and their families. Alongside specific medical considerations, the surgeons underscore surgical advancements that enhance safety and outcomes, reaffirming the potential for patients to regain a fulfilling life post-surgery.

---

EARN CME

Reflect on how this Podcast applies to your day-to-day and earn free AMA PRA Category 1 CMEs: https://earnc.me/wEWNiy

---

SHOW NOTES

00:00 - Introduction to Cancer Survivorship

08:06 - The Terrible Urological Five: When to Consider Cystectomy

23:09 - The Journey to Accepting a Cystectomy and Urinary Diversion

35:03 - Support Networks and Postoperative Quality of Life

38:53 - Concluding Thoughts and the Importance of Moving Forward

The discussion highlights the evolution of bladder cancer treatment, from the use of cytotoxic chemotherapy to the current practice of neoadjuvant chemotherapy and radical cystectomy. Dr. Lerner and Dr. Bagrodia further explore diagnostic and treatment strategies, including the role of Decipher Prostate Genomic Classifier in tailoring patient treatment plans. The podcast delves into the necessity of a multidisciplinary approach to bladder cancer, the benefits of multimodal therapy, and the integration of circulating tumor DNA in management plans. Dr. Lerner then discusses clinical trials assessing the impact of extended lymph node dissection during cystectomies and emphasizes the importance of surgical quality and adherence to established protocols in bladder cancer treatment.

---

CHECK OUT OUR SPONSOR

Veracyte

https://www.veracyte.com/decipher

---

SHOW NOTES

00:00 - Introduction

06:17 - The Role of Imaging in Bladder Cancer Staging

08:00 - Exploring the Potential of Genomic Classifiers

16:55 - Debating the Efficacy of Extended Lymph Node Dissection

27:47 - Update on Bladder Cancer Clinical Trials

48:54 - Final Thoughts and the Future of Bladder Cancer Treatment

Dr. Palapattu shares his personal journey from being inspired by mentors like Dr. Don Coffey to becoming Chief of Urologic Oncologist at Houston Methodist and his focus on fostering the next generation of medical professionals. The episode emphasizes the need for self-reflection, understanding one’s motivations, and the importance of maintaining relationships outside of the professional sphere. Additionally, the doctors discuss financial pressures on surgeon scientists and the importance of a supportive environment, along with the unique position of urologists in driving significant scientific and clinical advancements.

---

SHOW NOTES

00:00 - Introduction

07:30 - The Challenges and Importance of Being a Surgeon Scientist

13:36 - The Impact of Clinical Practice on Scientific Research

18:40 - Structuring Success in Academic Medicine

25:41 - Reflecting on the Culture of Collaboration and Support

27:24 - The Importance of Time and Resources in Academic Medicine

43:40 - Advice for Aspiring Surgeon Scientists

---

RESOURCES

Dr. Ganesh Palapattu’s Faculty Profile

https://medicine.umich.edu/dept/urology/ganesh-s-palapattu-md-facs

First, they explore Dr. Jordan’s multifaceted career, starting from his upbringing in El Paso and his military career, which eventually led him to medicine and urology. Dr. Jordan shares anecdotes from his time as a Navy fighter pilot and how his service influenced his medical path. He eventually chose to focus on reconstructive urology and played a pivotal role in the formation of the Society of Genitourinary Reconstructive Surgeons (GURS). Significant emphasis is placed on global surgical education and Dr. Jordan’s involvement in establishing and contributing to key nonprofits aimed at improving urological care worldwide. The podcast also delves into Dr. Jordan’s tenure at the American Board of Urology, and the urologists also discuss the evolving landscape of urology education and certification. Finally, Dr. Jordan reflects on the importance of mentorship, the joy of lifelong learning, and the future of urology as a fulfilling specialty.

---

SHOW NOTES

00:00 - From Fighter Pilot to Urologist

07:32 - Transitioning from the Military to a Medical Career

14:21 - The Evolution of Reconstructive Urology and Global Surgical Education

22:01 - Dr. Jordan’s Role in the American Board of Urology

26:31 - Reflecting on a Distinguished Career and Looking Ahead

---

RESOURCES

Society of Genitourinary Reconstructive Surgeons

https://societygurs.org/

BackTable Urology Episode 52- Legends in Urology: Dr. Jack McAninch

https://open.spotify.com/episode/46wrxyhB2XCwERp4Z2ySc0?si=fe62e35cff934e74

This week on BackTable Urology, Dr. Ruchika Talwar interviews Emmy nominated writer and comedian, Nimesh Patel, about his personal experience with testicular cancer.

Sharing about his diagnosis, treatment, and recovery, Nimesh describes how he processed his cancer and used it as a source of comedic material for his 2023 comedy special, “Lucky Lefty”. His story has contributed to testicular cancer awareness by encouraging men to do self-checks and seek medical attention. Nimesh also underlines the importance of swift medical attention, open communication with medical professionals, and finding a healthy outlet for processing the fear and stress that can accompany a cancer diagnosis. Finally, he emphasizes the importance of the patient-physician relationship, as his anxiety about his diagnosis was eased his physician’s calm demeanor and reassurance.

---

SHOW NOTES

00:00 - Introduction

02:06 - The Testicular Cancer Diagnosis and Personal Reflections

11:39 - Sharing His Cancer Journey through Comedy

19:56 - Advice for Physicians and Physicians

25:11 - Advice for Men Facing Testicular Cancer

27:36 - The Importance of Not Making Cancer Your Personality

---

RESOURCES

Nimesh Patel’s “Lucky Lefty” Comedy Special

https://www.youtube.com/watch?v=A2Rdh82XGrY

Episode 91- When Providers Become Patients: Testicular Cancer and Beyond with Dr. William Flanary aka. Dr. Glaucomflecken

https://open.spotify.com/episode/4JSXDRJ8BwzFhBBpCymCU3?si=8c58881f9b274cd0

First, he discusses topics such as patient preparation, pre-treatment discussions, and individualized treatment options based on the patient's risk levels. Dr. Eastham also summarizes crucial advancements in testing and imaging prostate cancers, including the use of genetic and biochemical markers, like PSA levels. Additionally, he emphasizes how advances in radiation therapy have improved treatment outcomes and patient experiences. Finally, Dr. Eastham emphasizes the need for consistent monitoring and communication with patients during and post-treatment.

---

CHECK OUT OUR SPONSOR

Veracyte

https://www.veracyte.com/decipher

---

SHOW NOTES

00:00 - Introduction

06:24 - Treatment Strategies and Patient Preferences

11:30 - Exploring the Role of Imaging in Prostate Cancer Treatment

18:29 - Dealing with Persistently Detectable PSA and Pre-op Staging

27:48 - Understanding Prostate Cancer Recurrence

36:08 - The Role of PSA Doubling Time in Treatment Decisions

43:34 - The Future of Personalized Medicine and Genomic Classifiers in Prostate Cancer

52:42 - The Importance of Patient Education and Preparation

---

RESOURCES

Decipher Prostate by Veracyte:

https://www.veracyte.com/decipher-prostate/

First, Dr. Holton shares her educational journey, which included healthcare policy lobbying even before she started medical school. She eventually became involved in leadership positions within the Maryland Patient Care and Access Coalition and the Large Urology Group Practice Association (LUGPA). The discussion then turns to challenges surrounding health policies, such as the persistent use of fee-for-service reimbursement guidelines despite the benefits of value-based care. Dr. Holton also highlights the critical issue of workforce shortages, particularly the need for urologists within rural areas and the impact of healthcare policy on patient access. She ends the episode by emphasizing the necessity for urologists to participate in policy advocacy efforts.

---

SHOW NOTES

00:00 - Introduction

04:58 - The Impact and Complexities of Healthcare Policies

07:27 - Success Stories in Healthcare Policy Advocacy

12:37 - The Impact of Prior Authorization Rules

14:27 - The Role of Pharmacy Benefit Managers in Healthcare

21:18 - The Challenges of Value-Based Care

32:48 - The Importance of Patient Access in Healthcare

41:24 - The Importance of Advocacy in Health Policy

---

RESOURCES

LUGPA website

https://www.lugpa.org/

Episode 82: Advocacy Basics for the Urologist: From Your Clinic to Capitol Hill with Dr. Ruchika Talwar

https://open.spotify.com/episode/0hcLrKuf5QU7TZCHSErs4Z?si=f4d06ffe6cff4cc4

First, Dr. Schaeffer introduces the importance of using a defined screening strategy for prostate cancer that includes analyzing a patient’s genomic and germline risk. Then, he summarizes existing and new diagnostic tools for prostate cancer. Additionally, Dr. Schaeffer discusses genomic testing and PSMA testing and explains how he applies them to individual patient cases depending on their cancer stage and grade. Finally, the doctors highlight the ability of future tools, like PET PSMA scans, to advance precision medicine.

---

EARN CME

Reflect on how this Podcast applies to your day-to-day and earn free AMA PRA Category 1 CMEs: https://earnc.me/3XO8iL

---

SHOW NOTES

00:00 - Introduction

10:32 - Precision Medicine and Prostate Cancer

16:17 - Screening and Diagnosis of Prostate Cancer

29:41 - Personalizing Surveillance and Disease Management

33:11 - The Role of Genomic Testing in Prostate Cancer

45:00 - The Use of PET PSMA Scans in Prostate Cancer Staging

48:08 - The Future of Precision Medicine in Prostate Cancer

First, Dr. Chew provides a comprehensive overview of the current landscape of laser treatment for kidney stones. Dr. Silva and Dr. Chew then discuss the unique characteristics of different laser types, such as the Holmium and the Thulium lasers. Dr. Chew also covers critical safety considerations, like maintaining low intravenous pressure, using cold irrigation, and taking breaks during sustained laser treatment. Additionally, they delve into emerging technology, such as the use of electromagnetic guidance, for more accurate laser application.

---

SHOW NOTES

00:00 - Introduction

06:49 - Choosing the Right Laser

12:11 - Energy Settings for Lasers

18:49 - Upper Tract Tumors and Lasers

23:54 - Preventing Thermal Injuries During Laser Treatment

27:03 - Dusting vs Fragmentation with Lasers

34:27 - The Impact of New Technologies on Kidney Stone Treatment

41:30 - Final Thoughts and Safety Recommendations

First, the doctors discuss the negative impacts of red and processed meat consumption as cancer-causing agents and encourage a shift towards whole, plant-based foods. They also emphasize the importance of engaging in regular physical activity and maintaining a healthy sleep schedule. Additionally, Dr. Loeb highlights substance abuse, particularly smoking and opioid consumption, as a health threat that needs to be managed. Lastly, the doctors discuss the importance of maintaining social connections and managing stress effectively in order to optimize preventative health.

---

CHECK OUT OUR SPONSOR

Veracyte

https://www.veracyte.com/decipher

---

SHOW NOTES

00:00 - Introduction

03:32 - The Importance of Lifestyle Medicine in Urology

07:57 - The Role of Nutrition in Cancer Prevention

14:07 - The Importance of Physical Activity

15:50 - The Impact of Sleep on Health

19:57 - Avoidance of Toxic Substances

34:02 - The Importance of Social Connections and Stress Management

---

RESOURCES

BackTable Urology Ep. 54 Smoking Cessation for the Urologist with Dr. Christian Fankhauser and Dr. Richard Matulewicz

https://open.spotify.com/episode/1LUfPqJY4eEiaMJFW2VCwt?si=03ce7b67cdce4cf5

BackTable Urology Ep. 28 Holistic and Integrative Approaches to Prostate Cancer with Dr. Geo Espinosa

https://open.spotify.com/episode/0XhnjdUGXXfZoU51miHhlS?si=7e743f1937044640

First, the doctors discuss significant transformation in the healthcare sector, with multiple corporations like Amazon, Walmart, and Best Buy entering the healthcare realm. Although earlier practices were physician-centric, the evolving trends show an inclination towards a more consumer-centric approach focusing on efficiency and value. The guests share their views on the necessity of doctors asserting their role in the changing landscape, emphasizing the importance of the doctor-patient relationship. The conversation also addresses innovations in the field such as value-based arrangements that prioritize patient experience while reducing costs.

---

SHOW NOTES

00:00 - Understanding Market Dynamics in Urology

02:18 - The Role of Big Corporations in Healthcare

07:14 - The Shift from Doctor-Centric to Patient-Centric Care

13:07 - The Commodification of Healthcare Services

19:36 - The Future of Healthcare: Vertical Integration

21:22 - The Impact of Value-Based Care on Healthcare

29:28 - The Role of Employers in Healthcare

41:50 - The Future of Healthcare: An Optimistic Outlook

First, they discuss impactful data regarding bladder cancers, specifically the CheckMate 901 and the EV-302 trials which show improvement in overall survival and promise for urothelial carcinoma patients’ quality of life. The conversation moves onto kidney-specific trials such as the LITESPARK-005, which offers improved progression-free survival for patients through the use of belzutifan. The panel rounds off by discussing the progress made in prostate-specific trials with emphasis on the EMBARK and SPLASH trials involving Lutetium therapy. Finally, the doctors discuss the trend towards personalized treatment plans based on the unique goals and health requirements of the patients.

---

SHOW NOTES

00:00 - Discussion on Urothelial Carcinoma: CheckMate 901 and EV-302

11:22 - Discussion on Kidney Cancer: LITESPARK-005

23:53 - Discussion on Prostate Cancer: EMBARK

31:41 - Discussion on Prostate Cancer: SPLASH vs PSMA

36:39 - Future Directions for Lutetium Therapy for Prostate Cancer

37:50 - Closing Remarks and Future Expectations

---

RESOURCES

CheckMate 901 Trial Investigators. Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma.

https://www.nejm.org/doi/full/10.1056/NEJMoa2309863

LBA6 EV-302/KEYNOTE-A39: Open-label, randomized phase III study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (Chemo) in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC).

https://www.sciencedirect.com/science/article/pii/S0923753423042709

LBA88 Belzutifan versus everolimus in participants (pts) with previously treated advanced clear cell renal cell carcinoma (ccRCC): Randomized open-label phase III LITESPARK-005 study.

https://www.sciencedirect.com/science/article/pii/S0923753423042345

LBA02-09 EMBARK: A Phase 3 Randomized Study of Enzalutamide or Placebo Plus Leuprolide Acetate and Enzalutamide Monotherapy in High-risk Biochemically Recurrent Prostate Cancer.

https://pubmed.ncbi.nlm.nih.gov/37119051/

177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy.

https://pubmed.ncbi.nlm.nih.gov/26795286/

One of his main focuses is to prioritize bladder health and end the polypharmacy approach to BPH. Dr. Kuang also introduces the 5 Stages of Bladder Health, emphasizing the risks if BPH is not treated effectively and earlier. He underlines the importance of strategic treatment planning based on detailed data collection of the patient’s prostate and bladder health. Dr. Kuang also examines different surgical and medical treatments for BPH. He ends the episode by explaining the Man vs. Prostate initiative and the significant global impact of his advocacy.

---

SHOW NOTES

00:00 - Introduction

02:01 - The Impact of BPH on Patients

05:57 - The Importance of Bladder Health

10:38 - The Five Stages of Bladder Health

23:00 - The Role of Primary Care Physicians in BPH Treatment

26:03 - The Role of Medications in Treating BPH

34:06 - The Role of Urologists in BPH Treatment

39:07 - The Importance of Personalized Therapy in BPH Treatment

44:17 - The Man vs. Prostate Initiative

---

RESOURCES

Dr. Wayne Kuang on LinkedIn

https://www.linkedin.com/in/wayne-kuang-md/

Man vs. Prostate

https://www.manvsprostate.com/

They explore topics such as the role of estrogen and testosterone in women’s sexual desire, FDA-approved medications for hypoactive sexual desire disorder, and the importance of sex education and communication within relationships. They also highlight the topic of gender inequality in sexual health care delivery and the lack of clinical resources specifically tailored to women’s needs. In sum, they aim to provide a deeper understanding of female sexual health and offer strategies for practitioners to provide more effective care.

---

SHOW NOTES

00:00 - Introduction

05:53 - The Role of Urologists in Women’s Sexual Health

07:18 - The Importance of Communication in Addressing Sexual Dysfunction

10:23 - The Role of the Clitoris in Female Orgasm

19:52 - Understanding the Hormones Behind Female Sexual Desire

25:32 - The Misconceptions and Gender Bias Surrounding Hormones

26:04 - The Role of Testosterone in Menopause and Sexual Desire

30:02 - The Challenges of Commercially Available Testosterone Products

32:52 - Non-Hormonal Treatments for Low Libido

42:41 - The Importance of Referring to Sex Therapists and Other Resources

---

RESOURCES

Dr. Kelly Casperson’s Website

https://kellycaspersonmd.com/

You Are Not Broken Podcast

https://kellycaspersonmd.com/you-are-not-broken-podcast/

“You Are Not Broken” by Kelly Casperson

https://kellycaspersonmd.com/you-are-not-broken-book/

“Magnificent Sex” by Peggy Kleinplatz

https://www.amazon.com/Magnificent-Sex-Lessons-Extraordinary-Lovers/dp/0367181371

American Association of Sexuality Educators, Counselors, and Therapists

https://www.aasect.org/

First, the doctors underscore the importance of ultrasound as the first line imaging modality to minimize fetal exposure to radiation. Dr. Sutherland and Dr. Desai also delve into nausea and pain management options, recommended diets for prevention of stone formation during pregnancy, and the necessity of involving a multidisciplinary team in such cases. The episode concludes with a remarkable case study from Dr. Desai’s experience.

---

SHOW NOTES

00:00 - Introduction

02:06 - Incidence and Risk Factors of Kidney Stones in Pregnancy

03:29 - Physiological Changes and Stone Formation in Pregnancy

07:04 - Diagnosing Kidney Stones in Pregnancy

13:08 - Expectant Management vs. Intervention

14:41 - Managing Pain and Nausea in Pregnant Patients with Kidney Stones

17:13 - Decompression Methods for Kidney Stones in Pregnancy

23:13 - Ureteroscopy as a Preferred Intervention

26:05 - Case Description from Dr. Desai

30:04 - Considerations for Ureteroscopy in Pregnant Patients

31:14 - Preventing Kidney Stones in Pregnancy

---

RESOURCES

Lyon, M., Sun, A., Shah, A., Llarena, N., Dempster, C., Sivalingam, S., Calle, J., Gadani, S., Zampini, A., & De, S. (2023). Comparison of Radiation Exposure for Pregnant Patients Requiring Intervention for Suspected Obstructing Nephrolithiasis. Urology, 182, 61–66. https://doi.org/10.1016/j.urology.2023.09.023

Thongprayoon, C., Vaughan, L. E., Chewcharat, A., Kattah, A. G., Enders, F. T., Kumar, R., Lieske, J. C., Pais, V. M., Garovic, V. D., & Rule, A. D. (2021). Risk of Symptomatic Kidney Stones During and After Pregnancy. American journal of kidney diseases : the official journal of the National Kidney Foundation, 78(3), 409–417. https://doi.org/10.1053/j.ajkd.2021.01.008

They discuss the conception and impact of virtual lecture series like EMPIRE and Urology COVID on residents’ education. They also underline how being adaptive and open to change can help residents shape the future of their own learning. The doctors also explain how resident-led and resident-focused educational resources came into existence, and what more is envisioned for education in urology. The episode ends with a discussion about unmet needs in education and the significance of diverse perspectives in teaching surgical procedures.

---

SHOW NOTES

00:00 - Introduction

01:15 - Reflections on Urology Education and Early Career Experiences

04:08 - The Evolution of Learning and Engagement in Medical Training

07:55 - Transitioning from Medical School to Residency

08:34 - The Creation of the Intern Academy for the American Urological Association

14:24 - The Impact of COVID-19 on Virtual Learning

16:12 - The Role of Residents in Virtual Learning

19:24 - The Future of Virtual Learning and Education

20:00 - The Role of Innovation and Adaptability in Education

23:07 - The Role of Residents in Shaping Their Own Learning

42:28 - The Future of Education in Urology

---

RESOURCES

AUA Intern Academy

https://auau.auanet.org/content/intern-academy-2023

AUA EMPIRE Lecture Series

https://nyaua.com/empire/

UCSF Urology Collaborative Online Virtual Didactics (COViD) Lecture Series

https://urologycovid.ucsf.edu/

First, they emphasize the importance of dispelling misconceptions about recurrent UTIs being a result of poor hygiene or incorrect behaviors, explaining that they can stem from genetic or hormonal risk factors. Dr. Cameron describes her algorithm for managing UTIs in specific patient populations. She further discusses the impact of factors such as fluid intake, bowel habits, and vaginal health on the incidence of UTIs. Dr. Cameron also highlights the potential for UTIs in diabetic patients on certain medications and the importance of a collaborative approach with diabetic healthcare teams. Additionally, the doctors explore various treatment strategies, such as cranberry supplements and gentamicin bladder installations, cautioning against antibiotic overuse due to the risk of resistance.

---

EARN CME

Reflect on how this Podcast applies to your day-to-day and earn free AMA PRA Category 1 CMEs: https://earnc.me/2P5fzK

---

SHOW NOTES

00:00 - Introduction

02:13 - Understanding UTIs: Definitions, Symptoms, and Prevalence

04:39 - Recurrent UTIs: Definitions, Causes, and Treatment Challenges

12:00 - Understanding Asymptomatic Bacteriuria

15:00 - Cystitis vs. Pyelonephritis vs. Urosepsis

20:57 - Antimicrobial Resistance and Antibiotic Stewardship

24:36 - Treatment Guidelines for UTIs

31:13 - Self-start Antibiotic Therapy for UTIs

34:37 - Preventing UTIs: Hydration, Lifestyle Factors, and Bowel Health

38:33 - The Connection Between Vaginal Health and UTIs

42:40 - The Role of Supplements in UTI Prevention: D-Mannose and Cranberry, and Methenamine Hippurate

57:18 - Identification and Treatment of UTIs in Patients with Indwelling Catheters

01:00:04 - The Role of Gentamicin Bladder Installations in UTI Prevention

01:04:27 - The Impact of Diabetes Medications on UTIs

---

RESOURCES

AUA Guidelines for UTI Treatment:

https://www.auanet.org/guidelines-and-quality/guidelines/recurrent-uti

Referencing official guidelines and personal experiences, the doctors discuss various treatments such as tumor ablation, JELMYTO, neoadjuvant chemotherapy, and nephroureterectomy. They also discuss the role of lymph node dissection and the significance of Lynch syndrome. Additionally, they touch upon the Thulium laser and updated staging guidelines. The episode concludes with discussions about follow-up care, and the doctors agree on the need for a standardized reporting system and risk stratification guidelines for improved patient management.

---

SHOW NOTES

00:00 - Introduction

02:09 - Initial Presentation of Patients with Upper Tract Urothelial Carcinoma

10:54 - Discussion on Lynch Syndrome

14:27 - Risk Stratification in Patients

15:37 - Tumor Ablation and Intracavitary Therapies

26:47 - The Use of Thulium Laser in Treatment

28:50 - Discussion on High Volume Disease

32:39 - Discussion on High Grade Tumors

38:23 - The Role of Neoadjuvant Chemotherapy

43:02 - Post-Treatment Follow Up

45:18 - Standardized Reporting in Guidelines

First, Dr. Kasraeian shares the process of learning Aquablation, the initial challenges he faced, and the benefits it offers patients. He explains that Aquablation is a procedure that democratizes the treatment of any size of the prostate by removing inconsistencies in management and offering a consistent, reproducible method. The doctors also discuss Aquablation outcomes and patient considerations, focusing on quality of life improvement and preserving ejaculatory function. Dr. Kasraeian also shares some insights on insurance coverage and billing for this procedure.

---

SHOW NOTES

00:00 - Introduction

03:34 - Dr. Ali Kasraeian’s Journey with Aquablation

07:31 - The Evolution of Aquablation Technique

12:14 - Criteria for Aquablation Candidates

29:59 - Starting Out with Aquablation: Tips and Tricks

33:24 - Preserving Ejaculatory Function: Patient Discussions and Planning

35:08 - Post-Procedure Follow-ups and Revisions

49:42 - Billing and Insurance Considerations for Aquablation

54:36 - Final Thoughts on Aquablation and Urology Innovation

---

RESOURCES

Kasraeian Urology

https://kasraeianurology.com/

Aquablation

https://aquablation.com/

Given the advancement in MRI guidance, the discussion addresses the opportunity for radiologists to step in and provide crucial expertise to optimize patient outcomes. Dr. Muasher talks about his approach of using an MR imaging to guide the biopsy procedure. He further expresses importance in understanding the grading, reading, interpreting systems like Prostate Imaging-Reporting and Data System (PI-RADS) and significant experience needed for accurate results. The doctors also explain various biopsy procedures, details about post-procedure care and follow-ups, and observations about billing for the services.

---

CHECK OUT OUR SPONSOR

Veracyte

https://www.veracyte.com/decipher

---

SHOW NOTES

00:00 - Introduction

07:29 - Learning to Read Prostate MRI

09:43 - The Role of Radiologists and Grading Systems in Prostate Biopsies

24:00 - Techniques in Prostate Biopsy

31:16 - The Role of Antibiotics in Biopsy

32:34 - The Debate Between Transperineal and Transrectal Biopsy

40:36 - Post-Procedure Care and Follow-Up

45:49 - The Future of Biopsy

---

RESOURCES

Decipher Prostate Genomic Classifier by Veracyte:

https://decipherbio.com/

They focus mainly on midurethral slings and a new urethral bulking agent called Bulkamid. They further analyze how conditions like product expectations, surgeon expertise, data availability, patient preferences, and financial costs influence the choice of procedure. Additionally, they discuss the impact of mesh-related complications and how they affected the usage of synthetic slings in the UK. Finally, they touch on the role of shared decision making in choosing treatment strategies.

---

EARN CME

Reflect on how this Podcast applies to your day-to-day and earn free AMA PRA Category 1 CMEs: https://earnc.me/p4RNfi

---

SHOW NOTES

00:00 - Introduction

03:48 - Discussion on Midurethral Slings

11:05 - The Mesh Controversy and Its Impact

22:21 - Shared Decision Making in Treatment Options

26:47 - The Role of Urethral Bulking Agents

32:51 - Comparative Trial and EAU Guidelines

42:12 - Conclusion and Closing Remarks

---

RESOURCES

Bulkamid Injections

https://bulkamid.com/en-US

The doctors go on to discuss how to ensure proper patient education and setting realistic expectations about post-surgery recovery. Additionally, they highlight the need for open conversation about sexual health and the use of hormone therapies to improve menopause symptoms. Finally, they touch on the need for more research in women’s sexual health and the use of pelvic floor physical therapy.

---

EARN CME

Reflect on how this Podcast applies to your day-to-day and earn free AMA PRA Category 1 CMEs: https://earnc.me/uYv0Hm

---

SHOW NOTES

02:30 - The Importance of Open Conversations about Sexual Health

03:55 - Addressing Sexual Health in Cancer Patients

11:47 - The Role of Hormones in Women’s Health

25:05 - The Renewed Interest in Gynecologic Organ Sparing

29:39 - Importance of Risks and Oncologic Outcomes in Bladder Cancer Treatment

35:56 - The Role of Pelvic Floor Physical Therapy in Bladder Cancer Recovery

44:24 - The Role of Hormone Therapy in Bladder Cancer Recovery

53:59 - Conclusion: The Future of Bladder Cancer Treatment

---

RESOURCES

Mark Cuban's Cost Plus Drug Company:

https://costplusdrugs.com/

---

CHECK OUT OUR SPONSOR

Boston Scientific GreenLight Laser Therapy

https://www.bostonscientific.com/greenlight

---

SHOW NOTES

First, the doctors discuss workup of BPH. Questionnaires, like the International Prostate Symptom Score (IPSS) are helpful when in the first clinic evaluation. They also discuss differential diagnoses of urinary obstructive symptoms.

Then, they discuss who is and isn’t a candidate for a GreenLight laser therapy. They also touch on the topic of pre-operative antibiotics. Dr. Chughtai then describes in detail the steps of the procedure to ensure an open channel and removal of the correct prostate lobes. Next, he discusses the possible risks and benefits of doing an ejaculatory hood sparing procedure. Additionally, they explore the hood technique and how it's used to preserve mucosa at the apex of the prostate.

They also consider the importance of having a discussion about ejaculation with patients before the GreenLight procedure. Additional technology or adjunctive medications, such as alpha blockers and PDE5 inhibitors may be necessary as well. Finally, Dr. Chughtai explains his post-operative medications and the decision to discharge or admit for overnight observation.

---

RESOURCES

GreenLight Laser Therapy:

https://www.bostonscientific.com/en-EU/health-conditions/enlarged-prostate/our-treatments/greenLight-laser-therapy.html

---

SHOW NOTES

Dr. Duke Herrell is a minimally invasive urologic surgeon and professor at Vanderbilt University. Dr. Herrell came to Vanderbilt for his surgical fellowship, where he met Bob Webster, a mechanical engineer who had developed concentric tube robots made out of an elastic metal. Together, they worked to form the metal into curves that could create a tentacle-like motion for clinical applications. Over the next 15 years, Dr. Herrell and three co-founders started their company, Virtuoso Surgical, and received grant funding to move forward with their startup.

The surgical device features two 1-millimeter dextrous tools inserted through a rigid scope that is capable of carrying a versatile array of instruments. The device is currently intended for the urologic procedures including removal and enucleation of prostate tissue, bladder lesion removal and sampling, and transurethral resection of bladder tumors (TURBT). Notably, the device addresses a critical issue in tumor staging by improving the accuracy of margin determination, which is a game-changer for the 50% of TURBT procedures that yield specimens lacking muscle or clear margin information. Beyond urology, the device has the potential to improve other surgical procedures that utilize a rigid scope in a constrained environment including pulmonology, neurosurgery, and ENT interventions.

Dr. Herrell and his team are also developing EndoTheia, a micromachine instrument that functions as a steerable catheter, specifically designed for flexible ureteroscopy. This device is currently in the verification and validation phase.

---

RESOURCES

Virtuoso Surgical:

https://virtuososurgical.net/

---

SHOW NOTES

First the doctors discuss the changing landscape of urologic oncology fellowships and the favorable job market for those graduating from residency. They also share how their experiences in residency and mentorship from esteemed urology professionals shaped their paths towards urologic oncology. Additionally, they discuss the Society of Urologic Oncology (SUO) Clinical Trials Consortium and its role in providing education and resources to fellows. Benefits of joining an SUO fellowship program include the ability to participate in clinical trials and gain mentorship opportunities.

Finally, the doctors examine the reality of balancing early career work and family responsibilities. They analyze the effect of burnout on our work-life balance and the different stages of career and family life. They conclude the episode by emphasizing the importance of intentionality in both aspects of their lives.

---

RESOURCES

SUO Clinical Trials Consortium

https://suoctc.org/home.aspx

---

SHOW NOTES

First, the doctors discuss when orchiectomy and retroperitoneal lymph node dissection (RPLND) are necessary. They also summarize the relevant tumor markers and laboratory values to obtain and discuss the possibility of teratomas. Then, they examine the role of chemotherapy in the treatment of metastatic testicular cancer.

The doctors then transition to explaining how to manage patient expectations before orchiectomy and RPLND. They discuss the various complications of the procedure as well as the potential benefits of using 3D models and animations to explain the surgery to patients. They also cover the complications of chemotherapy as well and emphasize the importance of preparing the patient for the side effects of all treatment combinations. Then, they delve into specific surgical techniques that can prevent surgical complications when resecting testicular cancers.

Finally, the doctors discuss the importance of gaining experience with observing RPLND and training at a high volume urology center to gain more insight into the complexities of the operation. Finally, they emphasize the importance of having an experienced team to handle the operation.

---

SHOW NOTES

First, the doctors explore the importance of cross-sectional imaging and IV contrast to identify and manage small renal masses. Many factors are important, such as patient age and comorbidities, hereditary cancer predisposition syndromes, and size cut-off criterias. They also emphasize the importance of time in helping patients understand their diagnosis and the individualized approach to each case.

Then, they move on to discuss the role of biopsies in identifying and managing small renal masses. Biopsies can determine whether a tumor is malignant and help with treatment decisions. They also discuss the AUA guidelines for when to consider a real biopsy as well as the risks and benefits of biopsy procedures. Then, they give a short summary of a few biopsy techniques.

After the renal biopsy, a decision has to be made about whether or not to operate on a small renal mass. Aditya and Christopher emphasize the importance of understanding patient goals and the risks of accidentally removing a benign tumor. They also explore factors in deciding on which patients would benefit from treatment of indolent tumors. Biopsies can help avoid over-treatment if they can be used to reduce unnecessary operations. The doctors end by discussing the follow-up and the importance of close monitoring for any signs of recurrence.

---

SHOW NOTES

Pelvic pain can originate from bladder-centric symptoms, pelvic floor dysfunction, GI-centric symptoms, gynecologic symptoms, musculoskeletal and psychosocial issues, and systemic problems. First, the doctors summarize how to perform a thorough pelvic physical exam. They explain how to identify the obturator muscles and levator complex with a digital exam. They differentiate between bladder-centric pain and pelvic floor-centric pain and emphasize not beginning with a speculum exam, which can cause pain in some patients. They also suggest using a speculum to check for masses or lesions and prescribing vaginal estrogen supplementation.

Then, Suzette and Priyanka examine the role of pelvic floor physical therapy in treating pelvic pain and how to communicate with patients about what to anticipate in physical therapy. In addition, Priyanka explains the approach to transvaginal injections for pelvic floor dysfunction, including the injection of a mix of long-acting anesthetics at 1, 3, 5, 7, 9, and 11 o'clock behind the pubic bone and deeper at the level of the ischial spine. Finally, she discusses the role of insurance coverage for these injections.

---

SHOW NOTES

First, David explains how laboratory and genetic tests can be useful when determining the cause of kidney stones. Obtaining a 24-hour urine sample and analyzing stone composition are important for understanding the causes of stone formation in teenagers. Environmental and genetic factors can also contribute to the formation of stones. For example, CYP24A1 mutation a gene can cause a hypersensitivity to vitamin D and calcium in the diet.

Next, David and Jose discuss lifestyle modifications for preventing stones in teenagers. They talk about how to limit sodium intake, the use of thiazide diuretics, and supplementing potassium citrate for calcium oxalate stones. Furthermore, they delve into the causes of hyperoxaluria, which are genetic primary hyperoxaluria and enteric hyperoxaluria. Additionally, they discuss the rare monosodium urate stones, which are usually associated with metabolic acidosis but can be caused by chronic diarrhea or eating a lot of protein.

The doctors end by discussing the challenges of transitioning pediatric management to adult management. Lastly, they discuss the potential causes of why more kids are forming stones, such as increasing sweet juices and fast food in the diet.